D-Wave Quantum Inc 10-Q for FY2026 Q3
D-Wave Quantum Inc. (QBTS)
10-Q
2026-11-16
For: 2026-09-30
View Original
Added on
November 16, 2026
About this 10-Q
D-Wave Quantum Inc filed this 10-Q on November 16, 2026, covering the quarter ended September 30, 2026 (FY2026 Q3).
D-Wave Quantum Inc. completed its Quantum Circuits acquisition on January 20, 2026 for 10,430,444 Common Shares and $250,000,000 in cash. Nine-month revenue fell to $10.4 million, while operating losses widened to $161.5 million. AI summary
Headline figures
Quarter ended September 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $4.51M
- up 20.7% from $3.74M a year earlier
- Net loss
- $48.2M
- compared with a net loss of $139.99M a year earlier
- Diluted EPS
- -$0.13
- compared with -$0.41 a year earlier
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________________
FORM 10-Q
________________________
(Mark One)
| QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |||||
For the quarterly period ended September 30, 2026
OR
| TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |||||
For the transition period from ___________ and ____________
Commission File Number: 001-41468
________________________
(Exact name of registrant as specified in its charter)
________________________
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | ||||
(Address of Principal Executive Offices) | (Zip Code) | ||||
(650 ) 285-2881
(Registrant's telephone number, including area code)
________________________
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | ☐ | Accelerated filer | ☐ | |||||||||||
| ☒ | Smaller reporting company | |||||||||||||
Emerging growth company | ||||||||||||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
APPLICABLE ONLY TO CORPORATE ISSUERS:
As of November 13, 2026, there were 376,886,897 outstanding shares of the registrant’s common stock, par value $0.0001 per share. In addition, there were 3,176,096 exchangeable shares outstanding as of November 13, 2026, which are convertible into shares of common stock on a one for one basis at any time for no consideration.
Table of Contents
| Page | ||||||||
| Cautionary Note Regarding Forward-Looking Statements | 2 | |||||||
Item 1. | ||||||||
Item 3. | Quantitative and Qualitative Disclosures About Market Risk | |||||||
Item 4. | Controls and Procedures | |||||||
Part II. Other Information | ||||||||
Item 1. | Legal Proceedings | |||||||
Item 1A. | Risk Factors | |||||||
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | |||||||
Item 3. | Defaults Upon Senior Securities | |||||||
Item 4. | Mine Safety Disclosures | |||||||
Item 5. | Other Information | |||||||
Item 6. | Exhibits | |||||||
Signatures | ||||||||
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
Certain statements in this Quarterly Report on Form 10-Q (this “Report”) may constitute “forward-looking statements” within the meaning of the federal securities laws, including the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Our forward-looking statements include, but are not limited to, statements regarding our and our management team’s expectations, hopes, beliefs, intentions or strategies regarding the future, including statements relating to our ability to help customers realize value from quantum computing, development of annealing and gate-model systems and extension of the capabilities of our hybrid and classical solvers, enterprise-scale adoption of quantum computing, statements relating to our development and commercialization plans, dual-platform roadmap and milestones, ability to satisfy the funding conditions of and to realize the anticipated benefits of the award from the U.S. Department of Commerce, and plans to accelerate the projected time to a scaled, error-corrected gate-model quantum computer, among others. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. In some cases, you can identify forward-looking statements by the following words: “believe,” “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “trend,” “estimate,” “predict,” “project,” “potential,” “seem,” “seek,” “future,” “outlook,” “forecast,” “projection,” “continue,” “ongoing,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. These statements involve risks, uncertainties, and other factors that may cause actual results, levels of activity, performance, or achievements to be materially different from the information expressed or implied by these forward-looking statements. We caution you that these statements are based on a combination of facts and factors currently known by us and our projections of the future, which are subject to a number of risks. Factors that might cause or contribute to a material difference the risks discussed in the Company’s other filings with the SEC, including in Part I, Item 1A, “Risk Factors” in our most recent Annual Report on Form 10-K, as supplemented and updated by subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K that we have filed or will file with the Securities and Exchange Commission (the “SEC”). You should not place undue reliance on these forward-looking statements in making an investment decision with respect to our securities. These forward-looking statements are not intended to serve as, and must not be relied on as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability regarding future performance, events or circumstances. Many of the factors affecting actual performance, events and circumstances are beyond our control. As a result of a number of known and unknown risks and uncertainties, our actual results or performance may be materially different from those expressed or implied by these forward-looking statements. All forward-looking statements set forth in this Report are qualified by these cautionary statements, and there can be no assurance that the actual results or developments we anticipate will be realized or, even if substantially realized, that they will have the expected consequence to or effects on us or our business or operations. These forward-looking statements are based on information available as of the date of this Report and current expectations, forecasts and assumptions, involve a number of judgments, risks and uncertainties, and are not predictions of actual performance. Accordingly, forward-looking statements should not be relied upon as representing our views as of any subsequent date, and we do not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.
2
Part I - Financial Information
Item 1. Financial Statements
D-Wave Quantum Inc.
Condensed Consolidated Balance Sheets
(Unaudited)
| September 30, | December 31, | ||||||||||
| (In thousands, except share and per share data) | 2026 | 2025 | |||||||||
| Assets | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ | $ | |||||||||
| Marketable investment securities | |||||||||||
| Trade accounts receivable, net | |||||||||||
| Inventories | |||||||||||
| Prepaid expenses and other current assets | |||||||||||
| Total current assets | |||||||||||
| Property and equipment, net | |||||||||||
| Operating lease right-of-use assets | |||||||||||
| Intangible assets, net | |||||||||||
| Goodwill | |||||||||||
| Other non-current assets, net | |||||||||||
| Total assets | $ | $ | |||||||||
| Liabilities and stockholders' equity | |||||||||||
| Current liabilities: | |||||||||||
| Trade accounts payable | $ | $ | |||||||||
| Accrued expenses and other current liabilities | |||||||||||
| Current portion of operating lease liabilities | |||||||||||
| Loans payable, net, current | |||||||||||
| Deferred revenue, current | |||||||||||
| Total current liabilities | |||||||||||
| Operating lease liabilities, net of current portion | |||||||||||
| Loans payable, net, non-current | |||||||||||
| Deferred revenue, non-current | |||||||||||
| Total liabilities | |||||||||||
| Commitments and contingencies (Note 12) | |||||||||||
| Stockholders' equity: | |||||||||||
Common stock, par value $ | |||||||||||
| Additional paid-in capital | |||||||||||
| Accumulated deficit | ( | ( | |||||||||
| Accumulated other comprehensive loss | ( | ( | |||||||||
| Total stockholders' equity | |||||||||||
| Total liabilities and stockholders’ equity | $ | $ | |||||||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
3
D-Wave Quantum Inc.
Condensed Consolidated Statements of Operations and Comprehensive Loss
(Unaudited)
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||||||||
| (In thousands, except share and per share data) | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||||||||
| Revenue | $ | $ | $ | $ | |||||||||||||||||||||||||
| Cost of revenue | |||||||||||||||||||||||||||||
| Total gross profit | |||||||||||||||||||||||||||||
| Operating expenses: | |||||||||||||||||||||||||||||
| Research and development | |||||||||||||||||||||||||||||
| General and administrative | |||||||||||||||||||||||||||||
| Sales and marketing | |||||||||||||||||||||||||||||
| Total operating expenses | |||||||||||||||||||||||||||||
| Loss from operations | ( | ( | ( | ( | |||||||||||||||||||||||||
| Other income (expense), net: | |||||||||||||||||||||||||||||
| Interest income | |||||||||||||||||||||||||||||
| Interest expense | ( | ( | ( | ( | |||||||||||||||||||||||||
| Gain on investment in marketable securities, net | |||||||||||||||||||||||||||||
| Change in fair value of warrant liabilities | ( | ( | |||||||||||||||||||||||||||
| Other income (expense), net | ( | ( | |||||||||||||||||||||||||||
| Total other income (expense), net | ( | ( | |||||||||||||||||||||||||||
| Loss before income taxes | ( | ( | ( | ( | |||||||||||||||||||||||||
| Income tax benefit (provision), net | |||||||||||||||||||||||||||||
| Net loss | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||||||||
| Net loss per share, basic and diluted | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||||||||
| Weighted-average shares used in computing net loss per share, basic and diluted | |||||||||||||||||||||||||||||
| Comprehensive loss: | |||||||||||||||||||||||||||||
| Net loss | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||||||||
| Other comprehensive income (loss), net of tax: | |||||||||||||||||||||||||||||
| Foreign currency translation adjustment | ( | ||||||||||||||||||||||||||||
| Unrealized losses on available-for-sale securities | ( | ( | |||||||||||||||||||||||||||
| Reclassification adjustment for realized gains (losses) included in net income | ( | ||||||||||||||||||||||||||||
| Total other comprehensive income (loss), net of tax | ( | ( | |||||||||||||||||||||||||||
| Net comprehensive loss | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||||||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
4
D-Wave Quantum Inc.
Condensed Consolidated Statements of Stockholders’ Equity
For the Three Months Ended September 30, 2026
(Unaudited)
| Common stock | Additional paid-in capital | Accumulated deficit | Accumulated other comprehensive loss | Total stockholders' equity | |||||||||||||||||||||||||||||||
| (In thousands, except share data) | Shares | Amount | |||||||||||||||||||||||||||||||||
| Balances at June 30, 2026 | $ | $ | $ | ( | $ | ( | $ | ||||||||||||||||||||||||||||
| Issuance of common stock in connection with exercise of stock options and vesting of RSUs | — | — | — | ||||||||||||||||||||||||||||||||
| Issuance of common stock to the U.S. Department of Commerce in connection with the OTA and SIA, net of issuance costs | ( | — | — | ( | |||||||||||||||||||||||||||||||
| Stock-based compensation | — | — | — | — | |||||||||||||||||||||||||||||||
| Tax withholding related to vesting of restricted stock units | — | — | ( | — | — | ( | |||||||||||||||||||||||||||||
| Other comprehensive loss | — | — | — | — | ( | ( | |||||||||||||||||||||||||||||
| Net loss | — | — | — | ( | — | ( | |||||||||||||||||||||||||||||
| Balances at September 30, 2026 | $ | $ | $ | ( | $ | ( | $ | ||||||||||||||||||||||||||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
5
D-Wave Quantum Inc.
Condensed Consolidated Statements of Stockholders’ Equity
For the Three Months Ended September 30, 2025
(Unaudited)
| Common stock | Additional paid-in capital | Accumulated deficit | Accumulated other comprehensive loss | Total stockholders' equity | |||||||||||||||||||||||||||||||
| (In thousands, except share data) | Shares | Amount | |||||||||||||||||||||||||||||||||
| Balances at June 30, 2025 | $ | $ | $ | ( | $ | ( | $ | ||||||||||||||||||||||||||||
| Issuance of common stock in connection with exercise of stock options and vesting of RSUs | — | — | |||||||||||||||||||||||||||||||||
| Issuance of common stock in connection with exercise of warrants | — | — | — | ||||||||||||||||||||||||||||||||
| Stock-based compensation | — | — | — | — | |||||||||||||||||||||||||||||||
| Tax withholding related to vesting of restricted stock units | — | — | ( | — | — | ( | |||||||||||||||||||||||||||||
| Foreign currency translation adjustment, net of tax | — | — | — | — | |||||||||||||||||||||||||||||||
| Net loss | — | — | — | ( | — | ( | |||||||||||||||||||||||||||||
| Balances at September 30, 2025 | $ | $ | $ | ( | $ | ( | $ | ||||||||||||||||||||||||||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
6
D-Wave Quantum Inc.
Condensed Consolidated Statements of Stockholders’ Equity
For the Nine Months Ended September 30, 2026
(Unaudited)
| Common stock | Additional paid-in capital | Accumulated deficit | Accumulated other comprehensive loss | Total stockholders' equity | |||||||||||||||||||||||||||||||
| (In thousands, except share data) | Shares | Amount | |||||||||||||||||||||||||||||||||
| Balances at December 31, 2025 | $ | $ | $ | ( | $ | ( | $ | ||||||||||||||||||||||||||||
| Equity issued as consideration for acquisition, net | — | — | |||||||||||||||||||||||||||||||||
| Issuance of common stock in connection with the Employee Stock Purchase Plan | — | — | — | ||||||||||||||||||||||||||||||||
| Issuance of common stock in connection with exercise of stock options and vesting of RSUs | — | — | — | ||||||||||||||||||||||||||||||||
| Issuance of common stock to the U.S. Department of Commerce in connection with the OTA and SIA, net of issuance costs | ( | — | — | ( | |||||||||||||||||||||||||||||||
| Stock-based compensation | — | — | — | — | |||||||||||||||||||||||||||||||
| Tax withholding related to vesting of restricted stock units | — | — | ( | — | — | ( | |||||||||||||||||||||||||||||
| Other comprehensive loss | — | — | — | — | ( | ( | |||||||||||||||||||||||||||||
| Net loss | — | — | — | ( | — | ( | |||||||||||||||||||||||||||||
| Balances at September 30, 2026 | $ | $ | $ | ( | $ | ( | $ | ||||||||||||||||||||||||||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
7
D-Wave Quantum Inc.
Condensed Consolidated Statements of Stockholders’ Equity
For the Nine Months Ended September 30, 2025
(Unaudited)
| Common stock | Additional paid-in capital | Accumulated deficit | Accumulated other comprehensive loss | Total stockholders' equity | |||||||||||||||||||||||||||||||
| (In thousands, except share data) | Shares | Amount | |||||||||||||||||||||||||||||||||
| Balance at December 31, 2024 | $ | $ | $ | ( | $ | ( | $ | ||||||||||||||||||||||||||||
| Issuance of common stock in connection with the Lincoln Park Purchase Agreement | — | — | — | ||||||||||||||||||||||||||||||||
| Issuance of common stock in at-the-market offerings, net of issuance costs | — | — | |||||||||||||||||||||||||||||||||
| Issuance of common stock in connection with the Employee Stock Purchase Plan | — | — | — | ||||||||||||||||||||||||||||||||
| Issuance of common stock in connection with exercise of stock options and vesting of RSUs | — | — | |||||||||||||||||||||||||||||||||
| Issuance of common stock in connection with exercise of warrants | |||||||||||||||||||||||||||||||||||
| Stock-based compensation | — | — | — | — | |||||||||||||||||||||||||||||||
| Tax withholding related to vesting of restricted stock units | — | — | ( | — | — | ( | |||||||||||||||||||||||||||||
| Foreign currency translation adjustment, net of tax | — | — | — | — | |||||||||||||||||||||||||||||||
| Net loss | — | — | — | ( | — | ( | |||||||||||||||||||||||||||||
| Balance at September 30, 2025 | $ | $ | $ | ( | $ | ( | $ | ||||||||||||||||||||||||||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
8
D-Wave Quantum Inc.
Condensed Consolidated Statements of Cash Flows
(Unaudited)
| Nine Months Ended September 30, | |||||||||||||||||
| (in thousands) | 2026 | 2025 | |||||||||||||||
| Cash flows from operating activities: | |||||||||||||||||
| Net loss | $ | ( | $ | ( | |||||||||||||
| Adjustments to reconcile net loss to cash used in operating activities: | |||||||||||||||||
| Depreciation and amortization | |||||||||||||||||
| Deferred income taxes | ( | ||||||||||||||||
| Stock-based compensation | |||||||||||||||||
| Amortization of operating right-of-use assets | |||||||||||||||||
| Provision for excess and obsolete inventory | ( | ||||||||||||||||
| Non-cash interest income | |||||||||||||||||
| Non-cash interest expense | |||||||||||||||||
| Change in fair value of warrant liabilities | |||||||||||||||||
| Gain on marketable equity securities | ( | ( | |||||||||||||||
| Unrealized foreign exchange loss (gain) | ( | ||||||||||||||||
| Other noncash items | |||||||||||||||||
| Change in operating assets and liabilities: | |||||||||||||||||
| Trade accounts receivable | ( | ( | |||||||||||||||
| Inventories | ( | ( | |||||||||||||||
| Prepaid expenses and other current assets | ( | ( | |||||||||||||||
| Trade accounts payable | ( | ||||||||||||||||
| Accrued expenses and other current liabilities | |||||||||||||||||
| Deferred revenue | ( | ||||||||||||||||
| Operating lease liability | ( | ( | |||||||||||||||
| Other non-current assets, net | ( | ( | |||||||||||||||
| Net cash used in operating activities | ( | ( | |||||||||||||||
| Cash flows from investing activities: | |||||||||||||||||
| Acquisition of business, net of cash acquired | ( | ||||||||||||||||
| Purchase of property and equipment | ( | ( | |||||||||||||||
| Purchases of marketable debt securities | ( | ||||||||||||||||
| Maturities of marketable debt securities | |||||||||||||||||
| Proceeds from recovery of previously written-off convertible note | |||||||||||||||||
| Expenditures for internal-use software | ( | ( | |||||||||||||||
| Net cash used in investing activities | ( | ( | |||||||||||||||
| Cash flows from financing activities: | |||||||||||||||||
| Proceeds from the issuance of common stock pursuant to the Lincoln Park Purchase Agreement | |||||||||||||||||
| Proceeds from the issuance of common stock in at-the-market offerings, net of issuance costs | |||||||||||||||||
| Proceeds from issuance of common stock upon exercise of warrants | |||||||||||||||||
| Proceeds from the issuance of common stock upon exercise of stock options | |||||||||||||||||
| Proceeds from common stock issued under the Employee Stock Purchase Plan | |||||||||||||||||
| Payment of tax withheld pursuant to stock-based compensation settlements | ( | ( | |||||||||||||||
| Repayments on TPC loan | ( | ||||||||||||||||
| Proceeds from equipment financing | |||||||||||||||||
| Payments for debt issuance costs | ( | ( | |||||||||||||||
| Repayment of equipment finance term loan | ( | ||||||||||||||||
| Payments of equity issuance costs | ( | ||||||||||||||||
| Net cash provided by (used in) financing activities | ( | ||||||||||||||||
| Effect of exchange rate changes on cash and cash equivalents | |||||||||||||||||
| Net increase (decrease) in cash and cash equivalents | ( | ||||||||||||||||
| Cash and cash equivalents at beginning of period | |||||||||||||||||
| Cash and cash equivalents at end of period | $ | $ | |||||||||||||||
| Supplemental disclosures of cash flow information: | |||||||||||||||||
| Cash Paid for Interest | $ | $ | |||||||||||||||
| Supplemental disclosure of non-cash investing and financing activities: | |||||||||||||||||
| Common stock issued for acquisition of business | $ | $ | |||||||||||||||
| Capitalized stock-based compensation | $ | $ | |||||||||||||||
| Inventory applied to capital projects | $ | $ | |||||||||||||||
| Reclassification of warrant liability to equity upon exercise | $ | $ | |||||||||||||||
| Debt issuance costs related to freestanding warrants | $ | $ | |||||||||||||||
| Operating lease right-of-use assets exchanged for new operating lease obligations | $ | $ | |||||||||||||||
| Purchases of property and equipment included in accounts payable | $ | $ | |||||||||||||||
| Unrealized gains (losses) on available-for-sale securities included in other comprehensive loss | $ | $ | |||||||||||||||
| Warrant exercise proceeds in transit | $ | $ | |||||||||||||||
| Equity issuance costs in accounts payable | $ | $ | |||||||||||||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
9
D-Wave Quantum Inc.
Notes to Condensed Consolidated Financial Statements
1. DESCRIPTION OF BUSINESS
D-Wave Quantum Inc. (“D-Wave” or the “Company”) was incorporated as a corporation organized and existing under the General Corporation Law of the State of Delaware on January 24, 2022. The Company was formed for the purpose of effecting a merger between DPCM Capital, Inc. (“DPCM”), D-Wave Systems Inc. (“D-Wave Systems”), and certain other affiliated entities through a series of transactions (the “Merger”) pursuant to the definitive agreement entered into on February 7, 2022 (the “Transaction Agreement”). On August 5, 2022, in conjunction with the Merger, DPCM and D-Wave Systems became wholly-owned subsidiaries of, and are operated by, the Company. Upon the completion of the Merger, the Company succeeded to all of the operations of its predecessor, D-Wave Systems.
D-Wave is focused on the development and delivery of quantum computing systems, software, and services. The Company is the world’s first commercial supplier of quantum computers, and the first to offer dual-platform quantum computing products and services, spanning both annealing and gate-model quantum computing technologies. The Company’s superconducting quantum computers provide sub-second response times and can be deployed on-premises or accessed through its LeapTM quantum cloud service (the “Leap service”), which offers 99.9 % availability and uptime. Customers apply D-Wave’s technology to address use cases spanning optimization, artificial intelligence, research and more. The Company's current sixth-generation annealing quantum computing system is named Advantage2TM.
We have four operating facilities, which we lease, in North America. These facilities are located in Burnaby, British Columbia, Richmond, British Columbia, Palo Alto, California, and New Haven, Connecticut. In addition, we plan to transition our corporate headquarters from Palo Alto, California to Boca Raton, Florida, and open a key U.S. R&D facility there under a new lease agreement.
2. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The unaudited interim condensed consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial reporting and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Certain information and footnote disclosure normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to instructions, rules and regulations prescribed by the United States Securities and Exchange Commission (“SEC”). In the opinion of the Company, the unaudited financial information for the interim periods presented reflects all adjustments, which are normal and recurring, necessary for a fair presentation of the condensed consolidated balance sheets, condensed consolidated statements of operations and comprehensive loss, and condensed consolidated statements of cash flows. Interim results should not be regarded as indicative of results that may be expected for any other period or the entire fiscal year.
The interim condensed consolidated financial statements included herein have been prepared on the same basis as the audited annual consolidated financial statements and reflect all adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods presented. These unaudited interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K as of and for the year ended December 31, 2025 filed with the SEC on February 26, 2026.
Principles of Consolidation
The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in the condensed consolidated financial statements upon consolidation.
10
Use of estimates
The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in the Company’s condensed consolidated financial statements and accompanying notes as of the date of the condensed consolidated financial statements. The most significant estimates and assumptions are used in determining: (i) inputs used to recognize revenue over time relating to costs estimated to complete the remaining performance obligations, (ii) standalone selling prices, (iii) fair value of financial instruments, (iv) long term revenue forecasts used in the accounting for the SIF Loan (see below and Note 9 for further information), (v) fair value of assets and liabilities acquired in business combinations, and (vi) asset impairment testing, including long-lived, intangible assets, and goodwill (tested at the reporting unit level). These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. On an ongoing basis, management evaluates its estimates as there are changes in circumstances, facts, and experience.
The Company’s accounting estimates and assumptions may change over time in response to risks and uncertainties, including uncertainty in the current economic environment due to inflation, tariffs, changes in interest rates and monetary policy, various geopolitical conflicts, and any evolutions thereof. The change could be material in future periods. As of the date of issuance of these condensed consolidated financial statements, the Company is not aware of any specific event or circumstances that would require the Company to update estimates, judgments or revise the carrying value of any assets or liabilities. Actual results may differ from those estimates or assumptions.
Intangible assets, net
The Company’s finite-lived intangible assets consist of developed technology and trademarks acquired in business combinations, as well as computer software acquired or capitalized in the ordinary course of business, including off-the-shelf software applications and costs associated with systems implementations. Finite-lived intangible assets are recorded at cost or, for assets acquired in a business combination, at their estimated acquisition-date fair values, less accumulated amortization and impairment. These assets are amortized on a straight-line basis over their estimated useful lives, which approximates the pattern in which the related economic benefits are expected to be consumed. Acquired developed technology is amortized over 15 years, trademarks are amortized over two years , off-the-shelf software is amortized over three years , and systems implementation costs are amortized over the initial license term. Annual license fees for off-the-shelf software are expensed as incurred. Finite-lived intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that their carrying amounts may not be recoverable.
Sales of future revenues
On November 20, 2020, the Company entered into an agreement with the Canada Strategic Innovation Fund (“SIF”), wherein SIF committed to providing a conditionally repayable loan to the Company in the amount of up to C$40.0 million (the “SIF Loan”). The SIF Loan is conditionally repayable according to a revenue-based formula. See Note 9 - Loans payable, net for additional information concerning the SIF Loan.
The accounting treatment for the SIF Loan considers the “sale of future revenues” guidance promulgated by ASC 470-10-25. The debt arising from the SIF Loan was recorded at face value and will be amortized using the effective interest method, leading to the accrual of interest expenses over the estimated term of the SIF Loan. The amortization schedule is based on projected cash flows derived from the Company's long-term revenue forecast. Subsequent changes in forecasted cash flows will be accounted for under the catch-up method, which entails adjusting the accrued interest portion of the principal balance through earnings to reflect the currently projected effective interest rate. The liability is classified as non-current, as the current forecast indicates that repayments will not commence within the 12 months following the balance sheet date.
11
Fair value of financial instruments
Certain assets and liabilities are carried at fair value under U.S. GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:
•Level 1—Quoted prices in active markets for identical assets or liabilities.
•Level 2—Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data.
•Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques.
The categorization of a financial instrument within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The Company recognizes transfers between levels of the fair value hierarchy on the date of the event or change in circumstances that caused the transfer. No assets or liabilities were classified as Level 3 during the nine months ended September 30, 2026 or 2025.
The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of September 30, 2026 and indicates the place in the fair value hierarchy of the valuation inputs the Company utilized to determine each such fair value (in thousands):
| Description | Level | As of September 30, 2026 | |||||||||
| Assets: | |||||||||||
| U.S. government bonds | 1 | $ | |||||||||
| Time deposits | 2 | $ | |||||||||
Revenue recognition
The Company recognizes revenue in accordance with Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers (Topic 606) and accounts for certain contract costs in accordance with FASB’s Accounting Standards Codification (“ASC”) 340-40, Other Assets and Deferred Costs-Contracts with Customers.
The core principle of ASC 606 is that an entity shall recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.
To support this core principle, the Company applies the following five step approach:
Step 1: Identify the contract with the customer
The Company executes signed contracts with customers for services sold through either its direct sales force or various reseller channels. Payment terms vary by arrangement and may include net 30 to 60-day terms, milestone billings, advance payments, and installment payments.
In arrangements with re-sellers of the Company’s services, the re-seller is considered the customer and the Company does not have any contractual relationships with the re-sellers’ end users. For these arrangements, revenue is recognized at the amount charged to the re-seller.
Upon initiation of a customer contract, an assessment is conducted by the Company regarding the customer's ability to pay for the services and/or products provided. This assessment encompasses various factors such as the customer's creditworthiness and past transaction history. Furthermore, periodic evaluations of customers' financial conditions are performed by the Company. The Company generally does not provide rights of return unless explicitly stated in the underlying contract.
Step 2: Identify the performance obligations
The Company’s contracts with customers often include multiple performance obligations. The Company's revenue contracts typically include one or more of the following performance obligations:
12
•Subscription access to its Leap service
•Professional services related to the development and implementation of quantum computing applications or to paid research projects
•Quantum computing systems, including related installation, calibration, commissioning, and customer-specific upgrade services when those promises are not separately identifiable
•Ongoing support and maintenance services
•Quantum computing application or system training
•Customer options, renewals, or future upgrade rights that may represent material rights.
The Company evaluates whether promised goods and services are distinct and therefore separate performance obligations, or whether they should be combined into a single performance obligation because they are not separately identifiable in the context of the contract.
Step 3: Determine the transaction price
The transaction price is the amount of consideration to which the Company expects to be entitled in exchange for transferring goods and services to the customer. Transaction prices may include fixed consideration, variable consideration, milestone payments, advance payments, installment payments, or other contractual amounts.
The Company evaluates whether variable consideration exists, including price concessions, credits, or service-level credits, and includes such amounts in the transaction price only to the extent that it is probable that a significant reversal of cumulative revenue recognized will not occur. The Company also evaluates whether payments to or on behalf of a customer should be accounted for as consideration payable to a customer rather than as a separate expense.
The Company assesses whether the contract contains a significant financing component by considering the difference between the promised consideration and the cash selling price of the promised goods or services, the timing of payments relative to transfer of control, the reason for that timing difference, and the discount rate that would apply in a separate financing transaction between the parties at contract inception. The Company has elected the practical expedient that permits an entity not to recognize a significant financing component if the time between the transfer of a good or service and payment is one year or less. When a significant financing component exists, the Company adjusts the transaction price to reflect the cash selling price of the promised goods or services and recognizes the financing effect separately from revenue using the effective-interest method.
The Company excludes from revenue government-assessed and imposed taxes on goods and services that are invoiced to customers.
Step 4: Allocate the transaction price to the performance obligations
When the Company determines that its contracts with customers contain multiple performance obligations, for these arrangements, the Company allocates the transaction price based on the relative standalone selling price (“SSP”) basis method by comparing the SSP of each distinct performance obligation to the total value of the contract. The Company uses SSP for products and services sold together in a contract to determine whether there is a variable consideration (e.g. discount) to be allocated based on the relative SSP of the various products and services. In instances where SSP is not directly observable, such as when the Company does not sell the product or service separately, the Company determines the SSP by considering its overall pricing objectives and market conditions, including cost plus a reasonable margin. Significant pricing practices taken into consideration include the Company’s discounting practices, the customer demographic, price lists, the Company's go-to-market strategy, historical and current sales, and contract prices. In instances where the Company does not sell or price a product or service separately, the Company maximizes the use of observable inputs by using information that may include market conditions.
When a contract includes a material right, the Company estimates the SSP of that option and allocates a portion of the transaction price to the material right. Revenue allocated to a material right is deferred and recognized when the related option is exercised or when the option expires unexercised.
Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation
The Company recognizes revenue when or as control of the promised good or service transfers to the customer. The Company’s Leap service and support and maintenance services are obligations that are satisfied over time by providing the customer with ongoing access to the Company’s resources. The Company uses the straight-line measure of progress to recognize revenue as these performance obligations are satisfied evenly over the respective service periods.
13
The Company’s professional services constitute an activity that creates benefits that the customer receives as the work is being performed. Therefore, professional services revenue is generally recognized over time using the labor hours incurred as input measure of progress. Certain paid research projects may be recognized at a point in time when research milestones are delivered to and accepted by the customer.
Revenue from quantum computing system sales is generally recognized over time during the installation period using an input method, with progress measured based on costs incurred to date relative to total estimated costs. From time to time, performance obligations arising from system sales may be recognized at a point in time if the circumstances of a sale preclude over time recognition. Revenue from system upgrade projects is also generally recognized over time using an input method, measuring progress based on costs incurred to date relative to total estimated costs. In applying a cost-to-cost measure of progress, the Company includes only those costs that depict performance in transferring control to the customer and excludes costs associated with abnormal inefficiencies or wasted materials.
The Company’s training performance obligations are satisfied at a point in time when control of the service transfers from the Company to the customer.
Revenue allocated to a material-right performance obligation is not recognized when the base contract is executed. Instead, the allocated amount is recognized when the customer exercises the option and the underlying promised goods or services are transferred, or when the option expires unexercised.
Contract assets and contract liabilities
The timing of revenue recognition, billings and cash collections may result in accounts receivable, contract assets, and contract liabilities on the Company’s consolidated balance sheets. A receivable is recorded in the period in which the Company provides services when it has an unconditional right to payment. Contract assets arise when the Company has transferred goods or services to the customer but the right to payment is conditional on something other than the passage of time. Contract assets may also arise when the cost to fulfill performance obligations recognized at a point in time are deferred until the performance obligation is complete. Contract liabilities (also referred to as deferred revenue) arise when the Company receives consideration before transferring the related goods or services. Deferred revenue is classified as current or non-current based on the expected timing of revenue recognition.
When a significant financing component exists, the Company separately recognizes the financing element as interest income or interest expense, as applicable, rather than as revenue.
Our contract acquisition costs represent incremental direct costs of obtaining a contract, primarily consisting of commissions and other incremental contract acquisition costs. When these costs are determined to be recoverable, we defer and amortize them over the contract term. Unamortized contract acquisition costs are included in other non-current assets, net on the condensed consolidated balance sheets, with related amortization expense recorded in sales and marketing expenses on the condensed consolidated statements of operations and comprehensive loss. The Company has elected to apply the practical expedient to expense contract acquisition costs as incurred when the expected amortization period is one year or less.
Cost of revenue
Cost of revenue for services consists of expenses related to delivering the Company’s services, consisting of direct labor costs, including stock-based compensation, direct services costs and depreciation and amortization related to the Company’s quantum computing systems and related software. These costs are expensed as incurred, as they relate to performance obligations that are being simultaneously satisfied as the work is performed.
Cost of revenue for quantum computing systems includes direct manufacturing costs, such as materials and labor for system production, as well as expenses related to installation, calibration, warranty, and support. Additionally, it includes shipping and handling costs associated with delivering the systems.
For system arrangements recognized over time using a cost-to-cost input method, cost of revenue also includes customer-specific fulfillment costs that directly relate to satisfying the performance obligation, including installation-enablement and site-preparation activities incurred after contract execution. Such costs are recognized in a manner consistent with the Company’s measure of progress.
14
Business Combination
The Company accounts for business combinations using the acquisition method of accounting, which requires the consideration transferred to be measured at fair value and allocated to the identifiable assets acquired and liabilities assumed based on their estimated acquisition-date fair values. On January 20, 2026, the Company completed the acquisition of Quantum Circuits, Inc. (“Quantum Circuits”), which was accounted for as a business combination under ASC 805. In connection with the acquisition, the Company recognized developed technology and trademarks as identifiable finite-lived intangible assets, both of which were valued using the relief-from-royalty method with the assistance of an independent valuation specialist. The excess of the purchase price over the estimated fair values of the identifiable net assets acquired was recorded as goodwill. If the accounting for a business combination is incomplete at the end of a reporting period, provisional amounts are recorded and may be adjusted during the measurement period, not to exceed one year from the acquisition date, for new information about facts and circumstances that existed as of the acquisition date. The results of operations of acquired businesses are included in the Company’s results beginning on the acquisition date. Acquisition-related costs incurred by the Company are expensed as incurred, while seller transaction expenses reimbursed by the Company are included in consideration transferred.
Net loss per share
Basic net loss per common share is computed by dividing the net loss available to common stockholders (the numerator) by the weighted-average number of shares of common stock, par value $0.0001 per share (“Common Shares”) outstanding (the denominator) during the period. Diluted net loss per common share is computed by dividing the net loss available to common stockholders adjusted by any preferred stock dividends declared during the period by the weighted average number of Common Shares and potential Common Shares outstanding when the impact is not antidilutive. Contingently issuable shares are included in basic Earnings Per Share (“EPS”) only when there is no circumstance under which those shares would not be issued. Shares issuable for little or no cash consideration are considered outstanding Common Shares and included in the computation of basic EPS.
U.S. Department of Commerce Award and Securities Issuance Agreement
On September 4, 2026, the Company entered into an Other Transaction Agreement (the “OTA”) with the U.S. Department of Commerce (the “Department”) under the CHIPS and Science Act, under which the Department agreed to provide an award of up to $100.0 million (the “Award” or the “CHIPS Act Award”) to support research and development of the Company's annealing and gate-model quantum computing systems. The Award is disbursed in tranches subject to the achievement of specified milestones. In connection with the OTA, on September 8, 2026, the Company entered into a Securities Issuance Agreement (the “SIA”) with the Department and issued to the Department 7,095,721 shares of its common stock (the “Shares”) at an issuance price of $14.093 per share, with no cash exchanged at closing. Please see Note 14 - Stockholders' equity for additional discussion of the CHIPS Act Award.
The Company accounted for the transaction as an equity issuance, with the uncollected contingent proceeds classified as contra-equity by analogy to the stock sale receivables guidance provided by ASC 505-10-45-2 and ASC 310-10-S99-2. The Company recorded the issuance at the $100.0 million of maximum consideration under the arrangement, offset by an equal contra-equity account that will be relieved as funds are collected. The equity and the contra-equity arising from the SIA are each recorded in additional paid-in capital on the condensed consolidated balance sheets. As of September 30, 2026, the Company had no t received any draws. Issuance costs of $1.1 million were recorded as a reduction to additional paid-in capital.
The OTA contains certain clawback provisions included as remedies for the Company’s material non-compliance with the OTA. These provisions are evaluated as potential loss contingencies. As of September 30, 2026, no loss under these provisions was probable, and no liability has been recognized.
Recent accounting pronouncements issued and adopted
None.
Recent accounting pronouncements not yet adopted
Expense Disaggregation Disclosures
In November 2024, the FASB issued ASU 2024-03, Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, requiring public entities to disclose additional information about specific expense categories in the notes to the financial statements on an interim and annual basis. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and for interim periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2024-03.
15
Capitalized Internal-Use Software Costs
In September 2025, the FASB issued ASU 2025-06, Accounting for Internal-Use Software Costs (Subtopic 350-40): Clarifying the Application of Capitalization Guidance, which amends the guidance on capitalizing costs related to internal-use software. ASU 2025-06 requires public entities to apply the disclosure requirements in ASC 360-10, Property, Plant, and Equipment, to capitalized internal-use software costs, regardless of how those costs are presented in the financial statements. The update is effective for fiscal years beginning after December 15, 2027, and interim reporting periods within those annual reporting periods, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2025-06.
Government Grants
In December 2025, the FASB issued ASU 2025-10, Government Grants (Topic 832): Accounting for Government Grants Received by Business Entities, which establishes comprehensive guidance for recognizing, measuring, presenting, and disclosing government grants received by business entities. Under this update, entities must apply specific recognition and measurement principles for both monetary and tangible non-monetary government grants, with the accounting outcome dependent on whether the grant is related to an asset or to income. ASU 2025-10 does not apply to not-for-profit entities and employee benefit plans and excludes certain types of transactions such as exchange transactions and government guarantees. The amendments are effective for fiscal years beginning after December 15, 2028, with early adoption permitted, and the Company is currently evaluating the impact of adopting ASU 2025-10.
3. BUSINESS COMBINATION
On January 20, 2026, the Company completed the acquisition of all of the issued and outstanding equity interests of Quantum Circuits, a privately held developer of superconducting gate-model quantum computing technology, pursuant to the Agreement and Plan of Merger dated January 6, 2026. The acquisition is intended to enhance the Company’s gate-model quantum computing capabilities by adding Quantum Circuits' dual-rail qubit technology and related intellectual property, together with complementary error-detection capabilities, to the Company’s scalable control systems, cryogenic infrastructure and cloud platform. The acquisition has been accounted for as a business combination under ASC 805, Business Combinations, with the Company identified as the accounting acquirer.
The Company incurred total acquisition-related costs of $12.0 million, including $2.9 million incurred during the year ended December 31, 2025. These costs were accounted for separately from the business combination and expensed as incurred in general and administrative expenses on the condensed consolidated statements of operations and comprehensive loss. Seller transaction expenses reimbursed by the Company were included in consideration transferred, while severance-related payments were recognized separately in post-combination compensation expense. In addition, the portion of replacement awards attributable to post-combination service will be recognized as compensation expense over the remaining service period.
The acquisition date was January 20, 2026, which is the date on which the Company obtained control of Quantum Circuits. The fair value of consideration transferred was $538.5 million, consisting of cash and equity consideration measured as of the acquisition date. The fair value of the Company’s Common Shares issued as consideration was based on the January 20, 2026 share price of $27.04 per share.
Consideration transferred was allocated to the tangible and intangible assets acquired and liabilities assumed based on their fair values as of the acquisition date. Management estimated the fair value of tangible and intangible assets and liabilities in accordance with the applicable accounting guidance for business combinations and utilized the services of third-party valuation consultants. The initial allocation of the consideration transferred is based on a preliminary valuation and may be adjusted as additional information becomes available during the measurement period. Balances subject to adjustment primarily include the valuations of acquired assets (tangible and intangible), liabilities assumed, as well as tax-related matters. During the measurement period, the Company may record adjustments to the provisional amounts recognized. The allocation of the consideration transferred will be finalized within the measurement period (up to one year from the acquisition date).
The following table summarizes the consideration transferred (in thousands):
| Amounts | |||||
| Cash consideration | $ | ||||
| Equity consideration | |||||
| Pre-acquisition portion of replacement equity awards | |||||
| Acquisition Consideration | $ | ||||
16
As of the acquisition date, the Company recognized the identifiable assets acquired and liabilities assumed based on their estimated fair values as follows (in thousands):
| Amounts | |||||
| Assets: | |||||
| Cash and cash equivalents | $ | ||||
| Prepaid expenses and other current assets | |||||
| Property and equipment, net | |||||
| Operating lease right-of-use assets | |||||
| Intangible assets | |||||
| Goodwill | |||||
| Total assets | $ | ||||
| Liabilities: | |||||
| Accounts payable | $ | ( | |||
| Current portion of right-of-use liability | ( | ||||
| Accrued and other current liabilities | ( | ||||
| Deferred Tax Liability | ( | ||||
| Total liabilities | $ | ( | |||
| Total purchase price | $ | ||||
The recognition of deferred tax liabilities in connection with the acquisition resulted in the release of certain preexisting valuation allowances on deferred tax assets, which was recorded as a deferred tax benefit on the condensed consolidated statements of operations and comprehensive loss.
Identifiable Intangible Assets
The Company identified two finite-lived intangible assets, developed technology and trademarks. The fair values assigned to the acquired developed technology and trademarks were estimated with the assistance of an independent third-party valuation specialist using the relief-from-royalty method, which estimates the value of an intangible asset based on the present value of the hypothetical royalty payments that the Company is relieved from paying by owning the asset rather than licensing it from a third party. Significant assumptions used in the valuations included projected revenues attributable to the acquired technology and trademarks, selected market-based royalty rates, estimated useful lives, expectations regarding technological obsolescence and the continued use of the Quantum Circuits brand, applicable tax rates and discount rates commensurate with the risks associated with the projected cash flows. Developed technology was assigned a useful life of 15 years and trademarks were assigned a useful life of 2 years. These intangible assets are being amortized on a straight-line basis over their respective useful lives.
The following table summarizes the acquired intangible assets (in thousands):
| Amounts | Useful life | |||||||
| Developed technology | $ | |||||||
| Trademarks | ||||||||
| Total intangible assets | $ | |||||||
Goodwill
Goodwill represents the excess of the purchase price over the fair value of the identifiable net assets acquired and reflects expected synergies, going-concern value, workforce-related value, and other future economic benefits that do not qualify for separate recognition. This goodwill is not deductible for income tax purposes.
17
Pro forma information (unaudited)
The following unaudited pro forma financial information presents the combined results of operations of the Company and Quantum Circuits as if the acquisition had occurred on January 1, 2025. The unaudited pro forma information includes adjustments for items directly attributable to the acquisition, including incremental amortization expense related to acquired intangible assets of $0.7 million and $11.0 million for the nine months ended September 30, 2026 and 2025, respectively, and non-recurring acquisition-related costs of $9.1 million assumed to have been incurred during the nine months ended September 30, 2025. The unaudited pro forma results do not reflect any operating efficiency or potential cost savings which may result from the integration of Quantum Circuits. Accordingly, these unaudited pro forma results are presented for informational purposes only and are not necessarily indicative of what the actual results of operation of the combined company would have been if the acquisition had occurred as of January 1, 2025.
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| (In thousands, except share and per share data) | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| Revenue | $ | $ | $ | $ | |||||||||||||||||||
| Loss from operations | ( | ( | ( | ( | |||||||||||||||||||
| Net loss | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||
| Net loss per share, basic and diluted | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||
| Weighted-average number of shares outstanding used to compute net loss per share, basic and diluted | |||||||||||||||||||||||
Quantum Circuits Revenue and Net Loss
The following table represents Quantum Circuits' revenue and losses included in the Company's condensed consolidated statements of operations and comprehensive loss subsequent to the Quantum Circuits acquisition date (in thousands):
| Period from January 20, 2026 through September 30, 2026 | |||||
| Revenue | $ | ||||
| Net loss | $ | ( | |||
4. REVENUE FROM CONTRACTS WITH CUSTOMERS
Disaggregation of revenue
Nature of Products and Services
The following table depicts the disaggregation of revenue by type of products or services and timing of transfer of products or services (in thousands):
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||||||||
| Type of products or services | |||||||||||||||||||||||||||||
| System sales | $ | $ | $ | $ | |||||||||||||||||||||||||
| QCaaS | |||||||||||||||||||||||||||||
| Professional services | |||||||||||||||||||||||||||||
| Other revenue* | |||||||||||||||||||||||||||||
| Total revenue | $ | $ | $ | $ | |||||||||||||||||||||||||
| Timing of revenue recognition | |||||||||||||||||||||||||||||
| Revenue recognized over time | $ | $ | $ | $ | |||||||||||||||||||||||||
| Revenue recognized at a point in time | |||||||||||||||||||||||||||||
| Total revenue | $ | $ | $ | $ | |||||||||||||||||||||||||
*Other revenue includes support and maintenance and printed circuit board sales.
18
Geographic Information
The following table presents a summary of revenue by geography for the three and nine months ended September 30, 2026 and 2025, based on customer location (in thousands):
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||||||||
| United States | $ | $ | $ | $ | |||||||||||||||||||||||||
| Japan | |||||||||||||||||||||||||||||
| Germany | |||||||||||||||||||||||||||||
| Canada | |||||||||||||||||||||||||||||
| Other | |||||||||||||||||||||||||||||
| Total revenue | $ | $ | $ | $ | |||||||||||||||||||||||||
“Other” includes the rest of Europe, the Middle East, the rest of Asia and Australia where the revenue from a single country is not greater than 10% of total consolidated revenue. In accordance with Company policy, the Company has not had any sales in China, Russia or Ukraine.
Significant customers
A significant customer is defined as one that comprises ten percent or more of total revenues in a particular period or ten percent of outstanding accounts receivable balance as of the period end.
The tables below present the significant customers on a percentage of total revenue basis for the three and nine months ended September 30, 2026 and 2025.
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||||||||
| Customer A | % | % | % | % | |||||||||||||||||||||||||
| Customer B | % | % | % | % | |||||||||||||||||||||||||
| Customer C | % | % | % | % | |||||||||||||||||||||||||
As of each of September 30, 2026 and 2025, there were three and two significant customers, respectively, that comprised ten percent or more of outstanding accounts receivable balances.
Contract balances
The following table provides information about accounts receivable, contract assets and liabilities as of September 30, 2026 and December 31, 2025 (in thousands):
| As of September 30, 2026 | As of December 31, 2025 | ||||||||||
| Trade accounts receivable and contract assets, net: | |||||||||||
| Trade accounts receivable, net of allowance for credit losses and excluding unbilled receivables | $ | $ | |||||||||
| Unbilled receivable contract asset | |||||||||||
| Contract acquisition costs | |||||||||||
| Capitalized fulfillment costs | |||||||||||
| Total contract assets | $ | $ | |||||||||
| Contract liabilities: | |||||||||||
| Deferred revenue, current | $ | $ | |||||||||
| Deferred revenue, non-current | |||||||||||
| Total contract liabilities | $ | $ | |||||||||
19
The allowance for credit losses related to trade accounts receivable was nominal as of September 30, 2026 and December 31, 2025. During the three and nine months ended September 30, 2026 and 2025, the Company recorded no write-offs of accounts receivable deemed uncollectible, respectively.
The revenue recognized in the condensed consolidated statements of operations and comprehensive loss that was included in the contract liability balance at the beginning of each period was $2.4 million and $18.2 million for the nine months ended September 30, 2026 and 2025, respectively.
Changes in deferred revenue from contracts with customers were as follows (in thousands):
| Nine Months Ended September 30, | |||||||||||
| 2026 | 2025 | ||||||||||
| Balance at beginning of period | $ | $ | |||||||||
| Deferral of revenue | |||||||||||
| Recognition of deferred revenue | ( | ( | |||||||||
| Balance at end of period | $ | $ | |||||||||
Remaining performance obligations
A significant number of the Company’s product and service sales are short-term in nature with a contract term of one year or less. For those contracts, the Company has utilized the practical expedient in ASC 606-10-50-14, exempting the Company from disclosure of the transaction price allocated to remaining performance obligations if the performance obligation is part of a contract that has an original expected duration of one year or less.
As of September 30, 2026, the aggregate amount of remaining performance obligations that were unsatisfied or partially unsatisfied related to customer contracts was $38.3 million, of which approximately 59 % is expected to be recognized to revenue in the next 12 months and 71 % is expected to be recognized to revenue in the next two years with the remainder to be recognized thereafter. Revenues allocated to remaining performance obligations represents the transaction price of noncancellable orders for which service has not been performed, which include deferred revenue and the amounts that will be invoiced and recognized as revenues in future periods from open contracts and excludes unexercised renewals.
5. MARKETABLE INVESTMENT SECURITIES
The Company holds investments in time deposits and in U.S. government bonds, which are classified as available-for-sale. The following table presents the components of the Company's available-for-sale debt securities as of September 30, 2026 and December 31, 2025:
| Amortized Cost | Unrealized | Estimated Fair Value | |||||||||||||||||||||
| Gains | Losses | ||||||||||||||||||||||
| As of September 30, 2026 | |||||||||||||||||||||||
U.S. government bonds | $ | $ | $ | $ | |||||||||||||||||||
| Time deposits | $ | $ | $ | $ | |||||||||||||||||||
| As of December 31, 2025 | |||||||||||||||||||||||
U.S. government bonds | $ | $ | $ | $ | |||||||||||||||||||
As of September 30, 2026, the Company held $224.0 million of available-for-sale debt securities, all of which had contractual maturities of one year or less.
20
6. BALANCE SHEET DETAILS
Inventories
Inventories consisted of the following (in thousands):
| As of September 30, 2026 | As of December 31, 2025 | ||||||||||
| Raw materials | $ | $ | |||||||||
| Work-in-process | |||||||||||
| Total inventories | $ | $ | |||||||||
Prepaid expenses and other current assets
Prepaid expenses and other current assets consisted of the following (in thousands):
| As of September 30, 2026 | As of December 31, 2025 | ||||||||||
| Prepaid services | $ | $ | |||||||||
| Interest receivable | |||||||||||
| Prepaid software | |||||||||||
| Prepaid insurance | |||||||||||
| Prepaid rent | |||||||||||
| Other | |||||||||||
| Total prepaid expenses and other current assets | $ | $ | |||||||||
Other non-current assets, net
Other non-current assets, net consisted of the following (in thousands):
| As of September 30, 2026 | As of December 31, 2025 | ||||||||||
| Investment in equity securities | $ | $ | |||||||||
| Deferred financing costs | |||||||||||
| Long-term deposits | |||||||||||
| Contract acquisition costs, net | |||||||||||
| Total | $ | $ | |||||||||
Equity Securities
During the nine months ended September 30, 2026, an observable transaction occurred in a class of securities held by the Company in one of our privately-held equity investees. Consequently, the carrying value of the Company’s investment was adjusted based on the transaction price, resulting in a net gain of $1.8 million. During the three months ended September 30, 2026 the Company received additional shares in an equity investee pursuant to an earn-out provision and recognized an additional net gain of $0.9 million. The gains are recorded in gain on investment in marketable securities, net on the condensed consolidated statements of operations and comprehensive loss.
Deferred financing costs
The deferred financing costs are deferred issuance costs related to the Equipment Financing Agreement. See Note 9 - Loans payable, net for additional information.
21
Accrued expenses and other current liabilities
Accrued expenses and other current liabilities consisted of the following (in thousands):
| As of September 30, 2026 | As of December 31, 2025 | ||||||||||
| Accrued compensation and related benefits | $ | $ | |||||||||
| Accrued professional services | |||||||||||
| Other accruals | |||||||||||
| Total accrued expenses and other current liabilities | $ | $ | |||||||||
7. PROPERTY AND EQUIPMENT, NET
Property and equipment, net consisted of the following (in thousands):
| As of September 30, 2026 | As of December 31, 2025 | ||||||||||
| Quantum computer systems | $ | $ | |||||||||
| Lab equipment | |||||||||||
| Computer equipment | |||||||||||
| Leasehold improvements | |||||||||||
| Furniture and fixtures | |||||||||||
| Construction-in-progress | |||||||||||
| Total property and equipment | |||||||||||
| Less: Accumulated depreciation | ( | ( | |||||||||
| Total property and equipment, net | $ | $ | |||||||||
Depreciation expense for the three months ended September 30, 2026 and 2025 was $1.2 million and $0.3 million, respectively. Depreciation expense for the nine months ended September 30, 2026 and 2025 was $3.0 million and $1.0 million, respectively.
8. INTANGIBLE ASSETS, NET
Intangible assets, net consisted of the following (in thousands):
| As of September 30, 2026 | As of December 31, 2025 | ||||||||||
| Developed technology | $ | $ | |||||||||
| Trademarks | |||||||||||
| Acquired software | |||||||||||
| Internally developed software | |||||||||||
| Other intangible assets | |||||||||||
| Total intangible assets | |||||||||||
| Less: Accumulated amortization | ( | ( | |||||||||
| Total intangible assets, net | $ | $ | |||||||||
Intangible assets are amortized on a straight-line basis over estimated useful lives ranging from 2.0 to 15.0 years, depending on the asset class, as described in Note 2 - Basis of Presentation and Summary of Significant Accounting Policies. Amortization expense for the three months ended September 30, 2026 and 2025 was $3.7 million and $49 thousand, respectively. Amortization expense for the nine months ended September 30, 2026 and 2025 was $10.5 million and $0.1 million, respectively.
22
Future Amortization
As of September 30, 2026, estimated future amortization expense is as follows (in thousands):
| Amounts | |||||
| 2026 (remaining) | $ | ||||
| 2027 | |||||
| 2028 | |||||
| 2029 | |||||
| 2030 | |||||
| Thereafter | |||||
9. LOANS PAYABLE, NET
Loans payable, net consisted of the following (in thousands):
| Effective Interest Rate | As of September 30, 2026 | As of December 31, 2025 | |||||||||||||||
| Loans payable, net, current: | |||||||||||||||||
| Equipment Financing Term Loan, current | $ | $ | |||||||||||||||
| Total loans payable, net, current | $ | $ | |||||||||||||||
| Loans payable, net, non-current: | |||||||||||||||||
| SIF Loan | Variable1 | $ | $ | ||||||||||||||
| Equipment Financing Term Loan, non-current | |||||||||||||||||
| Total loans payable, net, non-current | $ | $ | |||||||||||||||
1Refer below for additional information on the SIF Loan repayment period and effective interest rate.
SIF Loan
On November 20, 2020, the Company entered into the SIF Loan and subsequently received the full C$40.0 million in eight tranches between November 2020 and December 2023. Funds from the SIF Loan were used for various research and development projects.
Principal and interest amounts to be repaid under the SIF Loan are determined using a revenue-based formula, and are capped at 150 % of the principal amount. Repayments are due in up to 15 annual installments, commencing on April 30 of the second fiscal year following the fiscal year in which the Company first reports annual revenue of at least $70.0 million. If the Company fails to reach $70.0 million in annual revenue after 14 years from origination, or if the total of the 15 revenue-based annual installments is less than the principal amount, any remaining repayment obligation will be forgiven.
Repayments of the SIF Loan can also be triggered upon default of the agreement, termination of the agreement, or upon a change of control that has not been approved by the Canadian government. As of September 30, 2026, the Company is not aware of any events that would trigger default or termination of the agreement.
The gross proceeds of the SIF Loan were recorded as a liability related to the sale of future revenues (see Note 2 - Basis of Presentation and Summary of Significant Accounting Policies). As of September 30, 2026 and December 31, 2025, the Company calculated a weighted average effective interest rate for all tranches of 2.61 % based on the most recent long-term revenue projections at each reporting date.
The estimated fair value of the SIF Loan (Level 3) at September 30, 2026 was $15.0 million. The fair value of SIF Loan was valued using a discounted cash flow model, with significant assumptions relating to the amount and timing of future revenues and the appropriate discount rate.
23
Equipment Financing Term Loan
On August 1, 2025, the Company entered into an equipment financing agreement (the “Equipment Financing Agreement”). The agreement provides for a total conditional commitment of $13.8 million, with an initial draw of $0.5 million made upon execution. Amounts drawn under the agreement are recognized as a term loan (the “Equipment Financing Term Loan”). The remaining commitment is available until February 1, 2027, which may be extended to August 1, 2027 if at least $11.5 million is drawn by that date. On September 2, 2026, the Company drew an additional $7.2 million under the Equipment Financing Agreement.
A commitment fee of 1 % of the total conditional commitment was paid to the financial institution providing the Equipment Financing Agreement (the “Lender”) upon the initial draw. The Lender also received a ten-year warrant to purchase 21,563 Common Shares at an exercise price of $16.05 per share. A non-utilization fee of 3 % will apply to the undrawn portion of the first $11.5 million as of the termination date (either February 1, 2027 or August 1, 2027, as applicable).
The interest rate for each draw is fixed upon execution and is based on a spread of approximately 3.4 % over the Prime Rate (which was 7.5 % at signing), subject to a minimum rate of 10.9 %, which is the rate applied to the initial draw. The Lender holds a first-priority security interest in all financed equipment. The rate applied to the September 2026 draw is the same as the rate for the initial draw.
Debt issuance costs, including the commitment fee, legal and documentation costs, and the warrant value, are recorded as deferred issuance costs and reclassified to a contra-liability as draws are made. The End-of-Term Payment (4.0 % of the total amount financed under the Equipment Financing Agreement) is accreted as part of the loan’s effective interest rate. Deferred issuance costs are reviewed for recoverability, and any unamortized costs related to canceled draws or terminated facilities are expensed immediately. Cash payments for debt issuance costs are classified as financing activities in the condensed consolidated statements of cash flows.
As of September 30, 2026, the Company had drawn $7.7 million under the Equipment Financing Agreement. The carrying amount of the outstanding equipment financing at September 30, 2026 was $7.0 million, measured at amortized cost net of discounts. As of September 30, 2026, $0.6 million in deferred issuance costs had been reclassified to debt discount related to the draws and $0.4 million of deferred issuance costs remained unallocated.
The estimated fair value of the Equipment Financing Term Loan was $7.3 million (Level 2) at September 30, 2026. The fair value of the Equipment Financing Term Loan was valued using a discounted cash flow model, with key inputs relating to terms, discount rate and expectations for defaults and prepayments.
TPC Loan
24
10. WARRANT LIABILITIES
Public and Private Warrants
In conjunction with the Merger, the Company assumed 10,000,000 Public Warrants and 8,000,000 Private Warrants. As part of the Merger, each Public Warrant and Private Warrant that was issued and outstanding immediately prior to the Merger was automatically and irrevocably converted into one warrant of the Company.
Each such Warrant was exercisable at an exercise price of $11.50 for 1.4541326 Common Shares, or an approximate exercise price per Common Share of $7.91 , subject to adjustments. The Warrants were exercisable only for a whole number of Common Shares, and no fractional shares were issuable. The Warrants were originally scheduled to expire on August 5, 2027, unless earlier redeemed or liquidated.
Warrant Exercises
During the year ended December 31, 2025, 17,645,147 Warrants were exercised by holders in accordance with the Warrant Agreement. As a result of these exercises, during the year ended December 31, 2025, the Company issued 25,658,383 Common Shares. In connection with the exercises, during the year ended December 31, 2025, the Company received cash proceeds of $202.9 million and reclassified $340.4 million, representing the fair value of the warrant liabilities at the time of exercise, from warrant liabilities to additional paid-in capital. The fair value of the liability pertaining to the exercised Warrants was remeasured immediately prior to exercise, and the change in fair value was recognized within change in fair value of warrant liabilities in the condensed consolidated statements of operations and comprehensive loss.
Redemption of Warrants
On November 19, 2025, the Company redeemed the 270,820 remaining outstanding Public Warrants at a redemption price of $0.01 per warrant. The redemption was effected pursuant to the terms of the Warrant Agreement following the Company’s satisfaction of the applicable share price performance condition. As a result of the redemption, the Public Warrants ceased trading on the New York Stock Exchange prior to the redemption date and were subsequently delisted.
There were no Public or Private Warrants outstanding at September 30, 2026.
D-Wave Systems Warrant Transaction Agreements
In November 2020, contemporaneously with a revenue arrangement, D-Wave Systems entered into a contract pursuant to which D-Wave Systems agreed to cancel a previously issued warrant with a customer and replace it with a warrant to acquire up to 3,247,637 shares of its Class A Preferred Shares (the “Warrant Preferred Shares”), subject to certain vesting requirements. The warrant agreement was amended on August 5, 2022, contemporaneously with the closing of the Merger, to convert the Warrant Preferred Shares to a warrant to acquire up to 2,889,282 Common Shares of the Company in accordance with the conversion ratio of 0.889657 established in the Merger. The warrants vest based on various contractual milestones. The warrant agreement was terminated on November 28, 2022. As of the termination date of the agreement, approximately 40 % of the warrants had vested, resulting in warrants exercisable for up to 1,155,713 Common Shares remaining after the termination date. The vested warrants will remain exercisable for up to 1,155,713 Common Shares at an exercise price of $2.16 per Common Share until November 29, 2026. As of September 30, 2026, no additional Warrant Preferred Shares were vested or were probable of vesting.
Warrants Issued in Connection with Equipment Financing
In connection with the Equipment Financing Agreement, the Company issued warrants to purchase 21,563 Common Shares, as further described in Note 9 - Loans payable, net.
11. STOCK-BASED COMPENSATION
2020 Equity Incentive Plan
In April 2020, the Board of Directors of D-Wave Systems approved the 2020 Equity Incentive Plan (the “2020 Plan”) which provides for the grant of qualified incentive stock options (“ISO”) and non-qualified stock options (“NSO”), restricted stock, restricted stock units (“RSUs”) or other awards to the Company’s employees, officers, directors, advisors, and outside consultants. Following the Merger, awards outstanding under the 2020 Plan continued to be governed by the 2020 Plan; however, the Company will not grant any further awards under the 2020 Plan.
25
2022 Equity Incentive Plan
On August 5, 2022, the shareholders approved the D-Wave Quantum Inc. 2022 Equity Incentive Plan (the “2022 Plan”), which became effective immediately upon the closing of the Merger. While the 2022 Plan allows for the issuance of awards with a service condition, a performance condition, a market condition, or some combination of the three, to date, the Company has only issued awards subject to a service condition. Awards issued under the 2022 Plan have vesting periods ranging from under 1 year to 4 years from the original grant date, and all awards issued to date under the 2022 Plan will expire 10 years from the original grant date.
Share-based compensation awards are settled by issuing new shares.
Common stock option activity
The following table summarizes the Company’s stock option activity during the periods presented (in thousands except share and per share data):
| Number of options | Weighted average exercise price ($) | Weighted average remaining contractual term (years) | Aggregate intrinsic value ($) | ||||||||||||||||||||
| Outstanding as of December 31, 2025 | |||||||||||||||||||||||
| Granted | |||||||||||||||||||||||
| Exercised | ( | ||||||||||||||||||||||
| Forfeited and expired | ( | ||||||||||||||||||||||
| Outstanding as of September 30, 2026 | |||||||||||||||||||||||
| Options exercisable as of September 30, 2026 | |||||||||||||||||||||||
| Options unvested as of September 30, 2026 | |||||||||||||||||||||||
Restricted stock unit awards
The following table summarizes the RSU activity and related information under the 2022 Plan:
| Number of RSUs | Weighted average Grant Date Fair Value ($) | ||||||||||
| Unvested as of December 31, 2025 | |||||||||||
| Granted | |||||||||||
| Forfeited and expired | ( | ||||||||||
| Vested | ( | ||||||||||
| Unvested as of September 30, 2026 | |||||||||||
Stock-based compensation expense
The following table summarizes the stock-based compensation expense classified in the condensed consolidated statements of operations and comprehensive loss as follows (in thousands):
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||||||||
| Cost of revenue | $ | $ | $ | $ | |||||||||||||||||||||||||
| Research and development | |||||||||||||||||||||||||||||
| General and administrative | |||||||||||||||||||||||||||||
| Sales and marketing | |||||||||||||||||||||||||||||
| Total stock-based compensation | $ | $ | $ | $ | |||||||||||||||||||||||||
During the three months ended September 30, 2026 and 2025, total compensation cost capitalized as part of property and equipment and intangible assets was $0.1 million and $0.1 million, respectively. During the nine months ended September 30, 2026 and 2025, total compensation cost capitalized as part of property and equipment, intangible assets and contract assets was $0.6 million and $0.3 million, respectively.
26
As of September 30, 2026, total unrecognized stock-based compensation cost, net of estimated forfeitures, related to our unvested stock awards was $105.4 million. This amount is based on an estimated future forfeiture rate of 2.34 % per year and will be recognized over a weighted-average period of approximately 2.9 years.
12. COMMITMENTS AND CONTINGENCIES
Lease obligations
The Company primarily enters into leases for office space that are classified as operating leases. During the three months ended September 30, 2026 and 2025, total operating lease costs were $1.2 million and $0.4 million, respectively. During the nine months ended September 30, 2026 and 2025, total operating lease costs were $3.3 million and $1.5 million, respectively.
Litigation
From time to time, the Company may become involved in various legal proceedings in the ordinary course of its business and may be subject to third-party infringement claims.
In the normal course of business, the Company may agree to indemnify third parties with whom it enters into contractual relationships, including customers, lessors, and parties to other transactions with the Company, with respect to certain matters. The Company has agreed, under certain conditions, to hold these third parties harmless against specified losses, such as those arising from a breach of representations or covenants, other third-party claims that the Company’s products, when used for their intended purposes, infringe the intellectual property rights of such other third parties, or other claims made against certain parties. It is not possible to determine the maximum potential amount of liability under these indemnification obligations due to the Company’s limited history of prior indemnification claims and the unique facts and circumstances that are likely to be involved in each particular claim.
As of September 30, 2026, the Company was not subject to any material litigation or pending litigation claims. Subsequently, the Company received notice of the following matters:
Securities Litigation
On October 15, 2026, a putative stockholder class action was filed in the United States District Court for the Northern District of California against the Company and certain current and former members of our senior management, captioned Fessler v. D-Wave Quantum Inc., et al. (Case No. 3:26-cv-11953). On October 20, 2026, another action was filed in the same court captioned Lawrence v. D-Wave Quantum Inc., et al. (Case No. 3:26-cv-12155). Each action (together, the “Actions”) asserts claims under Sections 10(b) and 20(a) of the Exchange Act, alleging that the Company and certain of its current and former officers made materially false or misleading statements, including about the Company’s operational and financial performance and growth. The plaintiffs in the Actions seek unspecified monetary damages and an award of costs and expenses, including reasonable attorneys’ fees and expert fees. We believe these claims are without merit, and we intend to defend the matters vigorously.
On November 2, 2026, a stockholder, Christopher Crull, filed a derivative lawsuit in the United States District Court for the Northern District of California, Crull v. Baratz, et al. (Case No. 5:26-cv-13006), against the Company (as nominal defendant only) and certain of the Company’s current and former directors and officers for, among other things, breach of fiduciary duty. The complaint alleges that the named directors and officers issued or caused the Company to issue materially false or misleading statements, including about the Company’s performance and growth and the Company’s internal controls, and that the Company suffered damages as a result. The complaint seeks, among other things, unspecified damages and reforms to the Company’s corporate governance and internal procedures.
The ultimate outcome of any litigation is uncertain and unfavorable outcomes could have a negative impact on our results of operations and financial condition. Defending such proceedings is costly and can impose a significant burden on management and team members. The results of litigation cannot be predicted with certainty, but regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.
As we are unable to determine at this time whether any loss ultimately will occur or to estimate the range of such loss, no amount of loss has been accrued by us in our financial statements as of and for the three and nine months ended September 30, 2026. If the potential loss from any claim or legal proceeding is considered probable and the amount is reasonably estimable, we will accrue a liability for the estimated loss. Legal proceedings are inherently uncertain and as circumstances change, it is possible that the amount of any accrued liability may increase, decrease or be eliminated.
27
There are currently no other pending or, to our knowledge, threatened legal proceedings or claims against us that, in our opinion, are likely to have a material adverse effect on our business, operating results, financial condition or cash flows.
13. NET LOSS PER SHARE
The following tables set forth the computation of the basic and diluted net loss per share attributable to common stockholders for the three and nine months ended September 30, 2026 and 2025 (in thousands, except share and per share data):
| Three Months Ended September 30, | |||||||||||||||||
| 2026 | 2025 | ||||||||||||||||
| Numerator: | |||||||||||||||||
| Net loss attributable to common stockholders - basic and diluted | $ | ( | $ | ( | |||||||||||||
| Denominator: | |||||||||||||||||
| Weighted-average common stock outstanding | |||||||||||||||||
| Net loss per share attributable to common stockholders - basic and diluted | $ | ( | $ | ( | |||||||||||||
| Nine Months Ended September 30, | |||||||||||||||||
| 2026 | 2025 | ||||||||||||||||
| Numerator: | |||||||||||||||||
| Net loss attributable to common stockholders - basic and diluted | $ | ( | $ | ( | |||||||||||||
| Denominator: | |||||||||||||||||
| Weighted-average common stock outstanding | |||||||||||||||||
| Net loss per share attributable to common stockholders - basic and diluted | $ | ( | $ | ( | |||||||||||||
Since the Company was in a loss position for all periods presented, basic net loss per share is the same as diluted net loss per share for all periods as the inclusion of all potential Common Shares outstanding would have been anti-dilutive.
Potentially dilutive securities (upon conversion) that were not included in the diluted per share calculations because they would be anti-dilutive were as follows:
| As of September 30, | |||||||||||||||||
| 2026 | 2025 | ||||||||||||||||
| Public Warrants as converted to Common Shares (Note 10) | |||||||||||||||||
| D-Wave Systems Warrant Preferred Shares as converted to Common Shares (Note 10) | |||||||||||||||||
| Equipment Financing Agreement Warrant – Common Shares (Note 9) | |||||||||||||||||
| Stock options issued and outstanding | |||||||||||||||||
| Unvested restricted stock unit awards | |||||||||||||||||
| Total | |||||||||||||||||
28
14. STOCKHOLDERS' EQUITY
Preferred Stock
As of September 30, 2026, D-Wave Quantum Inc. is authorized to issue up to 20,000,000 shares of preferred stock. D-Wave Quantum Inc. has not issued any shares of preferred stock as of September 30, 2026 and 2025. As no shares have been issued, D-Wave Quantum Inc. preferred stock is not reflected on the consolidated balance sheet.
Equity Purchase Agreements
On January 10, 2025, the Company entered into its third at-the-market sales agreement (the “$150M ATM”), with Needham & Company, LLC, Stifel, Nicolaus & Company, Incorporated, B. Riley Securities, Inc., Roth Capital Partners, LLC, The Benchmark Company, LLC, and Craig-Hallum Capital Group, LLC (the “$150M ATM Agents”). Under this agreement, the Company could sell Common Shares with an aggregate offering price of up to $150.0 million through or to the $150M ATM Agents. During the three months ended March 31, 2025, the Company received $146.1 million in net proceeds through the issuance of 24,604,021 Common Shares. As of September 30, 2026, the Company had completed 100 % of the issuances available under the $150M ATM.
On June 10, 2025, the Company entered into its fourth at-the-market sales agreement (the “$400M ATM”), with Needham & Company, LLC, Evercore Group L.L.C., TD Securities (USA) LLC, Canaccord Genuity LLC, Mizuho Securities USA LLC, Piper Sandler & Co., Craig-Hallum Capital Group LLC and Rosenblatt Securities Inc. (collectively, the “$400M ATM Agents”). Under this agreement, the Company could sell Common Shares with an aggregate offering price of up to $400.0 million through or to the $400M ATM Agents. During the three months ended June 30, 2025, the Company received $390.6 million in net proceeds through the issuance of 26,344,831 Common Shares. As of September 30, 2026, the Company had completed 100 % of the issuances available under the $400M ATM.
Sales under these agreements were classified as “at-the-market” equity offerings under Rule 415(a)(4) of the Securities Act and conducted on the NYSE or other trading platforms. The $150M ATM Agents and $400M ATM Agents (collectively, the “Agents”) used commercially reasonable efforts to sell shares based on the Company’s instructions. The compensation to the Agents was up to 3.0% of the gross sales price, along with expense reimbursements. The Company also agreed to provide indemnification against certain liabilities under the Securities Act.
The Company was not obligated to sell shares under either of these sales agreements. Each agreement could have been terminated by: (a) the election of the applicable Agents upon the occurrence of certain adverse events, (b) business days’ advance notice from the Company to the applicable Agents or five days ’ advance notice from any of the applicable Agents to the Company or (c) otherwise by mutual agreement of the parties pursuant to the terms of the applicable sales agreement.
U.S. Department of Commerce Award and Securities Issuance Agreement
On September 4, 2026 (the “Award Date”), the Company entered into the Other Transaction Agreement with the U.S. Department of Commerce under the CHIPS and Science Act. The Department agreed to provide an award of up to $100.0 million to support research and development of the Company's annealing and gate-model quantum computing systems. The OTA contains other terms and conditions that are customary for agreements with the Department, including provisions giving the U.S. government a license to use intellectual property funded by the Award for government purposes, as well as march-in rights and provisions requiring domestic control and production of federally-funded inventions. The Department also has the right to exercise specified remedies, including termination and clawback provisions, upon the Company’s non-compliance with the OTA.
On September 8, 2026, in connection with the OTA, the Company entered into the Securities Issuance Agreement with the Department. Under the SIA, the Company issued 7,095,721 shares of common stock, par value $0.0001 per share, to the Department at $14.093 per share, or approximately $100.0 million in the aggregate. The issuance price equals the lowest reported closing price of the Company’s common stock on three dates (the date the Department first transmitted the draft letter of intent for the Award to the Company, the date the letter of intent was executed, and the Award Date), discounted by 15 %; the applicable reference price of $16.58 per share equaled the closing market price of the common stock on the Award Date.
The Award is disbursed in tranches based on the achievement of specified milestones. Of the total, $53.6 million became available at the Award Date; the remaining $46.4 million is subject to milestone achievement determinations made by the Department in its sole discretion. Funds drawn from the Award Date tranche or a subsequent tranche must be applied to eligible project costs within 30 days or returned. As of September 30, 2026, the Company has not received any funds pursuant to the Award.
29
While the Shares are held by a U.S. governmental entity or instrumentality or an entity in which the U.S. government holds a majority, controlling interest, the holder may not vote the Shares, except on matters as to which the holder is entitled to vote as a matter of law that would adversely affect the rights of the stock, or any business combination involving the Company. Absent the Company’s prior written consent, the Department may transfer only up to the number of Shares corresponding to the portion of the Award the Company has drawn (net of amounts returned); may not transfer any Shares from the time it delivers a notice terminating the OTA for convenience until 150 days after the end of the Award Period (or, if the Company exercises its repurchase right, until the related repurchase closing period expires); and may not transfer Shares in a privately negotiated transaction to a competitor or prospective competitor of the Company or to a transferee whose ownership of the Shares could cause the Company to violate the OTA.
The Department may terminate the OTA for convenience on 60 days’ prior written notice. If it does so before the end of the Award Period, the Company has the right, but not the obligation, exercisable by notice delivered no earlier than 120 and no later than 150 days after the end of the Award Period, to repurchase for $1.00 in aggregate, a number of Shares equal to the total Shares issued to the Department multiplied by the sum of the Award funds the Company did not receive plus any Award funds the Company returned to the Department prior to being applied to eligible project costs, divided by $100.0 million.
Warrant Exercises and Redemption
During the year ended December 31, 2025, 17,645,147 Warrants were exercised by holders in accordance with the terms of the Warrant Agreement. Refer to Note 10 - Warrant liabilities for further description of the Warrant exercises and redemption.
Common Shares
As of September 30, 2026, the Company had 379,681,691 shares of common stock outstanding, comprised of 3,176,096 Exchangeable Shares and 376,505,595 Common Shares. At any time and at their election, holders of Exchangeable Shares can exchange their shares for Common Shares on a one -for-one basis. In addition, holders of Exchangeable Shares have the same rights with respect to voting, dividends, and liquidation, dissolution, and winding up, as holders of Common Shares. As such, the Exchangeable Shares are identical in substance to Common Shares and, therefore, are treated as shares of common stock of the Company.
The rights pertaining to the Common Shares are as follows:
Voting Rights
Except as otherwise required by law or as otherwise provided in any certificate of designation for any series of preferred stock, the holders of Common Shares possess all voting power for the election of directors and all other matters requiring stockholder action. Holders of Common Shares are entitled to one vote per share on matters to be voted on by stockholders.
Dividend Rights
Holders of Common Shares will be entitled to receive dividends as and when declared by the Company's board of directors at its discretion out of funds properly applicable to the payment of dividends, subject to the rights, if any, of shareholders holding shares with special rights to dividends. The timing, declaration, amount and payment of future dividends will depend on the Company's financial condition, earnings, capital requirements and debt service obligations, as well as legal requirements, regulatory constraints, industry practice and other factors that the Company's board of directors deems relevant.
Rights Related to Liquidation, Dissolution and Winding Up
In the event of voluntary or involuntary liquidation, dissolution, distribution of assets or winding-up, the holders of Common Shares will be entitled to receive an equal amount per share of all of the Company's assets of whatever kind available for distribution to stockholders, after the rights of the holders of the preferred stock, if any, have been satisfied.
30
15. SEGMENT AND GEOGRAPHIC INFORMATION
The Company operates as one operating segment managed on a consolidated basis. The financial information regularly reviewed by the Chief Executive Officer, who serves as the Chief Operating Decision Maker (“CODM”), is presented on the same basis as the Company's consolidated financial statements. The measure of profit or loss used by the CODM to allocate resources and assess performance is consolidated net loss. Significant expense categories are not presented, as the expense information regularly provided to the CODM is presented on the same basis as the consolidated statements of operations and comprehensive loss. The CODM relies on consolidated net loss as a comprehensive measure of the Company, considering all revenues and expenses, including cost of revenue, research and development expenses, general and administrative expenses and sales and marketing expenses, to assess the Company’s overall performance and inform strategic decisions on cost control, pricing and investments. Additionally, the CODM reviews total assets to assess the Company's financial position and resource allocation. The CODM also reviews forward-looking expense information contained in budgets and operating plans to manage operations and allocate resources.
See the condensed consolidated financial statements and accompanying footnotes for consolidated net loss, total expenditures for additions to long-lived assets, total assets and other financial information regarding the Company’s single operating segment. See Note 4 - Revenue from contracts with customers for additional information about revenue by geography.
The following table sets forth the long-lived assets, consisting of property and equipment, net and operating lease right-of-use assets, by geographic area as follows (in thousands):
| As of September 30, 2026 | As of December 31, 2025 | ||||||||||||||||
| Canada | $ | $ | |||||||||||||||
| United States | |||||||||||||||||
| Other | |||||||||||||||||
| Total long-lived assets | $ | $ | |||||||||||||||
31
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
You should read the following discussion and analysis of our financial condition and results of operations in conjunction with our unaudited condensed consolidated financial statements and the accompanying notes contained in Part I, Item 1 of this Report, as well as our Annual Report on Form 10-K for the year ended December 31, 2025 filed with the SEC on February 26, 2026. The following discussion contains forward-looking statements based upon current expectations that involve risks, uncertainties and assumptions. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of various factors, including risks described in this Report, and the risk factors discussed in our Annual Report on Form 10-K for the year ended December 31, 2025 and our other filings with the SEC. Our historical results are not necessarily indicative of the results that may be expected for any period in the future. In this section, unless otherwise specified, the terms “we”, “our”, “us”, “D-Wave” or the “Company” refer to D-Wave Quantum Inc. and its subsidiaries following the closing of the Merger while “D-Wave Systems” refers to D-Wave Systems Inc. prior to such closing. All other capitalized terms have the meanings ascribed thereto elsewhere in this Report. All dollar amounts are expressed in thousands of United States dollars (“$”), unless otherwise indicated.
32
Overview
We are focused on the development and delivery of quantum computing systems, software, and services. We are the world’s first commercial supplier of quantum computers, and the first to offer dual-platform quantum computing products and services, spanning both annealing and gate-model quantum computing technologies. Our superconducting quantum computers provide sub-second response times and can be deployed on-premises or accessed through our LeapTM quantum cloud service (the “Leap service”), which offers 99.9% availability and uptime. Customers apply our technology to address use cases spanning optimization, artificial intelligence, research and more. Our current sixth-generation annealing quantum computing system is named Advantage2.
Our business model is focused on generating revenue from providing customers access to our quantum computing systems via the cloud in the form of quantum computing as a service (“QCaaS”) products, providing professional services wherein we assist our customers in identifying and implementing quantum computing applications, and selling our quantum computer systems to customers.
We have four operating facilities, which we lease, in North America. These facilities are located in Burnaby, British Columbia, Richmond, British Columbia, Palo Alto, California, and New Haven, Connecticut. In addition, we plan to transition our corporate headquarters from Palo Alto, California to Boca Raton, Florida, and open a key U.S. R&D facility there under a new lease agreement.
During the nine months ended September 30, 2026 and 2025, we generated revenue totaling $10.4 million and $21.8 million, respectively. We have incurred significant operating losses since inception. For the nine months ended September 30, 2026 and 2025, our operating losses were $161.5 million and $65.5 million, respectively, and our net losses were $114.6 million and $312.7 million, respectively. We expect to continue to incur significant losses for the foreseeable future as we continue to invest in a number of research and development programs as well as a variety of go-to-market initiatives. As of September 30, 2026, we had an accumulated deficit of $1.1 billion.
Acquisition of Quantum Circuits, Inc.
On January 20, 2026, we completed the acquisition (the “Acquisition”) of all of the issued and outstanding equity of Quantum Circuits, Inc. (“Quantum Circuits”), pursuant to the Agreement and Plan of Merger, dated January 6, 2026, by and among the Company, Quantum Circuits, Quest Acquisition Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of the Company, Quest Acquisition Merger Sub II, LLC, a Delaware limited liability company and a wholly owned subsidiary of the Company, and Shareholder Representative Services LLC, a Colorado limited liability company, solely in its capacity as the representative, agent and attorney-in-fact of the Securityholders (as defined therein) (the “Acquisition Agreement”). The aggregate consideration (the “Acquisition Consideration”) delivered at the closing of the Acquisition consisted of 10,430,444 Common Shares (the “Stock Consideration”) and $250,000,000 in cash, subject to a net debt adjustment and such other adjustments as set forth in the Acquisition Agreement. The issuance and sale of the Stock Consideration was made in reliance on the private offering exemption of Section 4(a)(2) of the Securities Act, Regulation D and/or Regulation S promulgated under the Securities Act. In accordance with the Acquisition Agreement, we assumed outstanding unvested options to purchase shares of Quantum Circuits common stock and adjusted such assumed options into options to purchase our Common Shares. Vested options and warrants to purchase Quantum Circuits common stock were cancelled in exchange for a pro rata portion of the Acquisition Consideration, subject to the adjustments described in the Acquisition Agreement.
Concurrently with the execution and delivery of the Acquisition Agreement, we entered into a lock-up agreement (each, a “Lock-Up Agreement”) with specified key employees of Quantum Circuits (each, a “Key Employee”) with respect to a portion of the Common Shares received as Acquisition Consideration, pursuant to which, subject to certain exceptions, each Key Employee may not transfer 50% of the Common Shares received by such Key Employee as Acquisition Consideration for a period of five years, subject to the terms and conditions of the Lock-Up Agreement, including accelerated release in specified events.
In addition, we and the former securityholders of Quantum Circuits (the “Securityholders”) entered into a Registration Rights Agreement under which the Securityholders have specified registration rights relating to the Stock Consideration. On January 20, 2026, we filed a Registration Statement on Form S-3ASR and a related prospectus supplement with the SEC, relating to the resale from time to time of up to 10,430,444 Common Shares by the Securityholders identified as selling stockholders in the prospectus supplement.
33
Transfer to The Nasdaq Stock Market LLC
In July 2026, we voluntarily transferred the listing and trading of our Common Shares from the New York Stock Exchange (the “NYSE”) to The Nasdaq Stock Market LLC (“Nasdaq”), retaining the ticker symbol “QBTS”. The listing and trading of our Common Shares on the NYSE ended as of market close on July 24, 2026 and trading of our Common Shares on Nasdaq began at market open on July 27, 2026.
U.S. Department of Commerce Award and Securities Issuance Agreement
As described in Note 14 - Stockholders' equity to the condensed consolidated financial statements, in September 2026, the Company entered into an arrangement with the U.S. Department of Commerce under which the Department agreed to provide up to $100.0 million of funding, in installments upon satisfying specified milestones and conditions, for the Company’s quantum computing research and development and received 7,095,721 shares of the Company’s common stock. The accounting treatment of this transaction is complex, and the Company voluntarily initiated a consultation with the SEC staff to seek confirmation that they do not disagree with the accounting treatment the Company has selected. As of the date of this filing, the consultation with the SEC staff has not been concluded. See Part II, Item 1A., “Risk Factors—Risk Factors Related to Our CHIPS Act Award” below.
Macroeconomic Environment
Unfavorable conditions in the economy in the United States, Canada and abroad, including conditions resulting from changes in inflationary pressure, gross domestic product growth, financial and credit market fluctuations, supply chain constraints, governmental actions and regulations such as international trade policies, tariffs and export controls, national security interests, political turmoil, natural catastrophes, outbreaks of contagious diseases, warfare and terrorist attacks in the United States, Europe or other parts of the world, including the continuing war in Ukraine, the war in Iran and resulting energy market disruptions and volatility in energy prices, and other conflicts in the Middle East, could cause a decrease in business investments in our products and services and negatively affect the growth of our business and our results of operations. While the impact of these macroeconomic conditions on our business, results of operations and financial position remains uncertain over the long term, to date, these unfavorable conditions have not affected our business.
Key Components of Results of Operations
Revenue
We currently generate our revenue through sales of quantum computer systems, subscription sales of our QCaaS service, professional services related to the development and implementation of quantum computing applications and delivery of quantum computing application development training.
Revenue from quantum computing system sales and system upgrade projects is generally recognized over time during the installation or upgrade period using an input method, with progress measured based on costs incurred to date relative to total estimated costs, a percentage-of-completion approach, as the criteria for over-time revenue recognition under ASC 606 are met. This approach is applied to system sales and upgrade projects that span multiple reporting periods and meet the criteria for over-time revenue recognition in accordance with ASC 606. From time to time, system sales may be recognized at a point in time if over time recognition is precluded. Both revenue from quantum computing system sales and revenue from system upgrade projects are classified within system sales in our financial statements. QCaaS revenue is recognized on a ratable basis over the contract term, which generally ranges from one quarter to multiple years. Professional services revenue, which includes QCaaS application development and paid research projects, is recognized over time on a percentage of completion basis using the costs incurred input measure of progress.
We expect revenue from system sales to become a larger component of our revenue mix. Because the timing of system installations and upgrades varies, and the related revenue is recognized over relatively short periods, our total revenue and revenue mix may fluctuate significantly from period to period, and period-over-period comparisons may not be indicative of future performance. We also expect QCaaS revenue to increase over time. Our professional services organization supports this growth by helping customers develop and deploy quantum applications, and we view professional services as a strategic enabler of long-term QCaaS adoption.
Cost of Revenue
Cost of revenue for quantum computing systems includes direct manufacturing costs, such as materials and labor for system production, as well as expenses related to installation, maintenance, and support. Additionally, it includes shipping and handling costs associated with delivering the systems. These costs are also expensed as incurred.
34
Cost of revenue also includes all direct and indirect expenses related to providing our QCaaS offering and delivering our professional services, such as personnel-related expenses, including stock-based compensation, costs associated with maintaining the Leap platform on which we provide the QCaaS service and depreciation and amortization related to our quantum computing systems and related software.
We expect our total cost of revenue to increase in absolute dollars over time, consistent with our anticipated revenue growth and the costs of supporting our customers, maintaining the Leap platform, manufacturing, installing and operating our quantum computing systems, and delivering our professional services. Because the timing of system installations and upgrades varies, our cost of revenue and gross margin may fluctuate from period to period depending on the relative contribution of system sales, QCaaS, and professional services to our revenue.
Operating Expenses
Our operating expenses consist of research and development, general and administrative, and sales and marketing expenses.
Research and Development
Research and development expenses consist primarily of personnel-related expenses, including salaries, benefits and stock-based compensation for personnel, fabrication costs, lab supplies, and cloud computing resources and allocated facility costs for our research and development functions. Research and development expenses also include purchased hardware components, fabrication and software costs related to quantum computing systems constructed for research purposes that do not have a high probability of providing near-term future economic benefits, and may have no alternate future use. We currently do not capitalize any research and development expenses.
We expect our research and development expenses will trend upward on an absolute dollar basis for the foreseeable future as we continue to invest in research and development efforts to enhance the performance of our annealing quantum computers, further develop our gate-model quantum computer, advance our superconducting bump bond process, upgrade our printed circuit board packaging manufacturing, and broaden the functionality and improve the reliability, availability and scalability of our Leap service. If in the future we receive government grants and research incentives, which have historically offset a portion of research and development costs, these costs could decrease in absolute dollars. Also, non-cash stock-based compensation expenses may cause upward and downward fluctuations in these costs from time to time.
General and Administrative
General and administrative expenses consist primarily of personnel-related expenses, including salaries, benefits and stock-based compensation for personnel and outside professional services expenses including legal, audit and accounting services, insurance, other administrative expenses and allocated facility costs for our administrative functions.
We expect our general and administrative expenses to increase in absolute dollars for the foreseeable future as we continue to invest in more comprehensive compliance and governance functions, increased IT security and compliance, and expanded internal controls over financial reporting in accordance with the Sarbanes-Oxley Act. However, non-cash stock-based compensation expenses may cause upward and downward fluctuations in these costs from time to time.
Sales and Marketing
Sales and marketing expenses consist primarily of personnel-related expenses, including salaries, benefits and stock-based compensation for personnel, direct advertising, marketing and promotional material costs, sales commission expense, consulting fees and allocated facility costs for our sales and marketing functions. We intend to continue to make significant investments in our sales and marketing organization to drive additional revenue, expand our global customer base, and broaden our brand awareness.
We expect our sales and marketing expenses to continue to increase in absolute dollars for the foreseeable future. However, non-cash stock-based compensation expenses may cause upward and downward fluctuations in these costs from time to time.
35
Results of Operations
Comparison of the Three Months Ended September 30, 2026 and 2025
| Three Months Ended September 30, | Variance | ||||||||||||||||||||||
| (In thousands, except share and per share data) | 2026 | 2025 | Amount | % | |||||||||||||||||||
| Revenue | $ | 4,513 | $ | 3,739 | $ | 774 | 21 | % | |||||||||||||||
| Cost of revenue | 2,127 | 1,070 | 1,057 | 99 | % | ||||||||||||||||||
| Total gross profit | 2,386 | 2,669 | (283) | (11) | % | ||||||||||||||||||
| Operating expenses: | |||||||||||||||||||||||
| Research and development | 31,543 | 14,075 | 17,468 | 124 | % | ||||||||||||||||||
| General and administrative | 13,100 | 9,383 | 3,717 | 40 | % | ||||||||||||||||||
| Sales and marketing | 11,225 | 6,947 | 4,278 | 62 | % | ||||||||||||||||||
| Total operating expenses | 55,868 | 30,405 | 25,463 | 84 | % | ||||||||||||||||||
| Loss from operations | (53,482) | (27,736) | (25,746) | 93 | % | ||||||||||||||||||
| Other income (expense), net: | |||||||||||||||||||||||
| Interest income | 4,864 | 8,581 | (3,717) | (43) | % | ||||||||||||||||||
| Interest expense | (350) | (201) | (149) | 74 | % | ||||||||||||||||||
| Gain on investment in marketable securities, net | 882 | 850 | 32 | 4 | % | ||||||||||||||||||
| Change in fair value of warrant liabilities | — | (121,859) | 121,859 | (100) | % | ||||||||||||||||||
| Other income (expense), net | (179) | 379 | (558) | (147) | % | ||||||||||||||||||
| Total other income (expense), net | 5,217 | (112,250) | 117,467 | (105) | % | ||||||||||||||||||
| Loss before income taxes | (48,265) | (139,986) | 91,721 | (66) | % | ||||||||||||||||||
| Income tax benefit (provision), net | 68 | — | 68 | n/a | |||||||||||||||||||
| Net loss | (48,197) | (139,986) | 91,789 | (66) | % | ||||||||||||||||||
Revenue
Revenue increased to $4.5 million for the three months ended September 30, 2026 as compared to $3.7 million for the three months ended September 30, 2025. Professional services increased by $1.5 million, and QCaaS revenue increased by $0.8 million offset by a decrease in system sales revenue of $1.5 million.
Cost of Revenue
Cost of revenue increased by $1.0 million, or 99%, to $2.1 million for the three months ended September 30, 2026 as compared to $1.1 million for the three months ended September 30, 2025. The increase in cost of revenue was primarily due to an increase in personnel costs of $0.9 million driven by more paid research projects, and an increase in stock-based compensation costs of $0.2 million.
Operating Expenses
Research and Development Expenses
Research and development expenses increased by $17.4 million, or 124%, to $31.5 million for the three months ended September 30, 2026 compared to $14.1 million for the three months ended September 30, 2025. The increase was primarily driven by increases in personnel costs of $8.5 million, depreciation and amortization expense of $4.2 million and stock-based compensation expense of $2.8 million.
General and Administrative Expenses
General and administrative expenses increased by $3.7 million, or 40%, to $13.1 million for the three months ended September 30, 2026 as compared to $9.4 million for the three months ended September 30, 2025. The increase was primarily driven by increases in personnel expenses of $1.7 million, stock-based compensation expense of $0.6 million, and software costs of $0.7 million.
36
Sales and Marketing Expenses
Sales and marketing expenses increased by $4.3 million, or 62%, to $11.2 million for the three months ended September 30, 2026 as compared to $6.9 million for the three months ended September 30, 2025. The increase was primarily driven by increases in personnel costs of $2.1 million, marketing expenses of $1.0 million and stock-based compensation expense of $0.7 million.
Other Income (Expense), net
Interest income
Interest income decreased by $3.7 million, or 43%, to $4.9 million for the three months ended September 30, 2026 as compared to $8.6 million for the three months ended September 30, 2025. The decrease was driven primarily by lower cash and investment balances.
Interest Expense
Interest expense increased modestly to $0.4 million for the three months ended September 30, 2026 as compared to $0.2 million for the three months ended September 30, 2025.
Gain on investment in marketable securities, net
Gain on investment in marketable securities was $0.9 million for each of the three months ended September 30, 2026 and three months ended September 30, 2025.
Change in fair value of warrant liabilities
The change in fair value of warrant liabilities was zero for the three months ended September 30, 2026 as compared to $121.9 million for the three months ended September 30, 2025. The Company had no Public Warrants outstanding following the redemption of all remaining warrants on November 19, 2025 pursuant to the Warrant Agreement.
Other income (expense), net
Other income (expense), net decreased by $0.6 million or 147%, to a net other expense of $0.2 million for the three months ended September 30, 2026 as compared to a net other income of $0.4 million for the three months ended September 30, 2025. The decrease was primarily driven by the impact of net foreign exchange movements.
37
Comparison of the Nine Months Ended September 30, 2026 and 2025
The following table sets forth our results of operations for the periods indicated (in thousands):
| Nine Months Ended September 30, | Variance | ||||||||||||||||||||||
| (In thousands, except share and per share data) | 2026 | 2025 | Amount | % | |||||||||||||||||||
| Revenue | $ | 10,447 | $ | 21,835 | $ | (11,388) | (52) | % | |||||||||||||||
| Cost of revenue | 4,539 | 3,313 | 1,226 | 37 | % | ||||||||||||||||||
| Total gross profit | 5,908 | 18,522 | (12,614) | (68) | % | ||||||||||||||||||
| Operating expenses: | |||||||||||||||||||||||
| Research and development | 85,575 | 37,057 | 48,518 | 131 | % | ||||||||||||||||||
| General and administrative | 48,763 | 26,491 | 22,272 | 84 | % | ||||||||||||||||||
| Sales and marketing | 33,057 | 20,503 | 12,554 | 61 | % | ||||||||||||||||||
| Total operating expenses | 167,395 | 84,051 | 83,344 | 99 | % | ||||||||||||||||||
| Loss from operations | (161,487) | (65,529) | (95,958) | 146 | % | ||||||||||||||||||
| Other income (expense), net: | |||||||||||||||||||||||
| Interest income | 15,677 | 15,991 | (314) | (2) | % | ||||||||||||||||||
| Interest expense | (864) | (633) | (231) | 36 | % | ||||||||||||||||||
| Gain on investment in marketable securities, net | 2,762 | 850 | 1,912 | 225 | % | ||||||||||||||||||
| Change in fair value of warrant liabilities | — | (259,964) | 259,964 | (100) | % | ||||||||||||||||||
| Other income (expense), net | 818 | (3,451) | 4,269 | 124 | % | ||||||||||||||||||
| Total other income (expense), net | 18,393 | (247,207) | 265,600 | (107) | % | ||||||||||||||||||
| Loss before income taxes | (143,094) | (312,736) | 169,642 | (54) | % | ||||||||||||||||||
| Income tax benefit (provision), net | 28,512 | — | 28,512 | n/a | |||||||||||||||||||
| Net loss | (114,582) | (312,736) | 198,154 | (63) | % | ||||||||||||||||||
| Foreign currency translation adjustment | 153 | 1,384 | (1,231) | (89) | % | ||||||||||||||||||
| Unrealized losses on available-for-sale securities | (195) | — | (195) | n/a | |||||||||||||||||||
| Reclassification adjustment for realized gains (losses) included in net income | (16) | — | (16) | n/a | |||||||||||||||||||
| Net comprehensive loss | $ | (114,640) | $ | (311,352) | $ | 196,712 | (63) | % | |||||||||||||||
Revenue
Revenue for the nine months ended September 30, 2026 was $10.4 million, a decrease of $11.4 million, or 52%, from revenue of $21.8 million for the nine months ended September 30, 2025. The decrease was primarily driven by a decrease in system sales of $14.8 million, reflecting revenue recognized in the prior year period upon the installation and processor upgrade of a sold system, partially offset by an increase in QCaaS revenue of $1.6 million and an increase in professional services revenue of $1.9 million.
Cost of Revenue
Cost of revenue increased by $1.2 million, or 37%, to $4.5 million for the nine months ended September 30, 2026 as compared to $3.3 million for the nine months ended September 30, 2025. The increase in cost of revenue was primarily due to an increase in personnel-related costs driven by more paid research projects.
Operating Expenses
Research and Development Expenses
Research and development expenses increased by $48.5 million, or 131%, to $85.6 million for the nine months ended September 30, 2026 compared to $37.1 million for the nine months ended September 30, 2025. The increase was primarily driven by increases in personnel costs of $19.7 million, depreciation and amortization of $11.6 million and stock-based compensation expense of $8.8 million.
General and Administrative Expenses
General and administrative expenses increased by $22.3 million, or 84%, to $48.8 million for the nine months ended September 30, 2026 as compared to $26.5 million for the nine months ended September 30, 2025. The increase was primarily driven by an increase in professional fees of $7.2 million (largely comprised of transaction expenses from the Acquisition), an increase in personnel expenses of $6.1 million and acquisition-related insurance expenses of $2.0 million.
38
Sales and Marketing Expenses
Sales and marketing expenses increased by $12.6 million, or 61%, to $33.1 million for the nine months ended September 30, 2026 as compared to $20.5 million for the nine months ended September 30, 2025. The increase was primarily driven by increases in personnel costs of $5.7 million, marketing expenses of $3.2 million, and stock-based compensation expense of $2.0 million.
Other Income (Expense), net
Interest income
Interest income decreased by $0.3 million, to $15.7 million for the nine months ended September 30, 2026 as compared to $16.0 million for the nine months ended September 30, 2025. The decrease was driven primarily by a lower cash and cash equivalent balances and the Company’s investment in short-term government debt.
Interest expense
Interest expense increased modestly to $0.9 million for the nine months ended September 30, 2026 as compared to $0.6 million for the nine months ended September 30, 2025.
Gain on investment in marketable securities, net
Gain on investment in marketable securities, net was a gain of $2.8 million for the nine months ended September 30, 2026 as compared to $0.9 million for the nine months ended September 30, 2025. The gain in the current period was attributable to an observable price change resulting from a third-party transaction involving the Company’s investment in a privately-held company. Accordingly, the carrying value of the investment was adjusted based on the transaction price, resulting in a net gain.
Change in fair value of warrant liabilities
The change in fair value of warrant liabilities was zero for the nine months ended September 30, 2026 as compared to a decrease of $260.0 million for the nine months ended September 30, 2025. The fair value of the warrant liabilities varied primarily with the trading price of the Public Warrants, which were listed on the NYSE. The trading price of the Public Warrants decreased during the nine months ended September 30, 2025, generally in line with the decline in the trading price of the Common Shares, resulting in a corresponding decrease in the fair value of the warrant liabilities. The Company had no Public Warrants outstanding following the redemption of all remaining warrants on November 19, 2025 pursuant to the Warrant Agreement.
Other income (expense), net
Other income (expense), net increased by $4.3 million or 124%, to a net other income of $0.8 million for the nine months ended September 30, 2026 as compared to a net other expense of $3.5 million for the nine months ended September 30, 2025. The increase was primarily driven by the impact of net foreign exchange movements in the prior period of $4.2 million resulting from appreciation of the U.S. Dollar against certain foreign currencies.
Income tax benefit (provision), net
Income tax benefit (provision), net was $28.5 million for the nine months ended September 30, 2026 as compared to zero for the nine months ended September 30, 2025. The increase was primarily driven by deferred tax liabilities assumed in connection with the Quantum Circuits acquisition. The deferred tax liabilities provided an additional source of taxable income required to utilize existing deferred tax assets, which resulted in the partial release of the valuation allowance against the deferred tax assets.
Liquidity and Capital Resources
The Company has historically raised capital through equity issuances, including at-the-market (“ATM”) offerings, an Equity Line of Credit (“ELOC” or “Lincoln Park Purchase Agreement”) with Lincoln Park Capital Fund, and warrant exercises.
As of December 31, 2025, the Company had completed all issuances under its prior equity programs, including the ELOC and its ATM sales agreements. During the year ended December 31, 2025, the Company received significant net proceeds from these programs, as well as from warrant exercises, which strengthened its liquidity position.
The Company has no Public Warrants outstanding during 2026 following the redemption of all remaining warrants in November 2025 pursuant to the Warrant Agreement.
39
The Company entered into the Equipment Financing Agreement in August 2025, which provides a conditional commitment of up to $13.8 million to finance certain capital equipment purchases. Refer to Note 9 - Loans payable, net to the condensed consolidated financial statements for additional information.
As described in Note 14 - Stockholders' equity to the condensed consolidated financial statements, in September 2026, the Company entered into an arrangement with the U.S. Department of Commerce under which the Department agreed to provide up to $100.0 million of staged funding for the Company’s quantum computing research and development and received 7,095,721 shares of the Company’s common stock. Of the total, $53.6 million became available at September 4, 2026, which is referred to in the agreement as the “Award Date”; the remaining $46.4 million is subject to milestone achievement determinations made by the Department in its sole discretion, and there can be no assurance as to the timing or amount of any future availability. Funds drawn from the Award Date tranche or a subsequent tranche must be applied to eligible project costs within 30 days or returned. As of September 30, 2026, the Company had not received any funds from the Award.
Cash Flows
The following table sets forth our cash flows for the periods indicated (in thousands):
| Nine Months Ended September 30, | |||||||||||||||||
| 2026 | 2025 | ||||||||||||||||
| Net cash provided by (used in): | |||||||||||||||||
| Operating Activities | $ | (109,025) | $ | (53,610) | |||||||||||||
| Investing Activities | (241,894) | (1,567) | |||||||||||||||
| Financing Activities | (5,199) | 712,044 | |||||||||||||||
| Effect of exchange rate changes on cash and cash equivalents | 137 | 1,384 | |||||||||||||||
| Net increase (decrease) in cash and cash equivalents | $ | (355,981) | $ | 658,251 | |||||||||||||
Cash Flows Used in Operating Activities
Our cash flows from operating activities are significantly affected by the growth of our business, and are primarily related to research and development, sales and marketing and general and administrative activities. Our operating cash flows are also affected by our working capital needs and fluctuations in our working capital balances.
For the nine months ended September 30, 2026, net cash used in operating activities was $109.0 million, an increase of $55.4 million from $53.6 million for the nine months ended September 30, 2025. The change is primarily due to a decrease in net loss of $198.2 million, offset by an increase in cash released from working capital of $13.8 million (primarily related to the recognition of deferred revenue) and a decrease in noncash items added back to net loss of $267.4 million (primarily related to decreased non-cash charges related to remeasurement of the warrant liability, offset by increased non-cash deferred tax benefits).
Cash Flows Used in Investing Activities
Net cash used in investing activities during the nine months ended September 30, 2026 was $241.9 million, an increase of $240.3 million from $1.6 million for the nine months ended September 30, 2025. The increase primarily reflects cash consideration for the Acquisition of $252.8 million during the nine months ended September 30, 2026. There was no similar activity during the nine months ended September 30, 2025.
Cash Flows Provided by Financing Activities
Net cash used by financing activities during the nine months ended September 30, 2026 was $5.2 million, as compared to net cash provided by financing activities of $712.0 million for the nine months ended September 30, 2025. The change is primarily due to a decrease in proceeds from the issuance of Common Shares pursuant to equity offerings of $574.5 million, and a decrease in proceeds from warrant exercises of $139.2 million.
40
Contractual Obligations and Commitments
As of September 30, 2026, there have been no material changes with regard to contractual obligations from those disclosed in our “Management's Discussion and Analysis on Financial Condition and Results of Operations—Contractual Obligations and Commitments” in our Annual Report on Form 10-K for the year ended December 31, 2025.
Critical Accounting Estimates
There have been no material changes to our critical accounting policies from those disclosed in our “Management's Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Estimates” in our Annual Report on Form 10-K for the year ended December 31, 2025.
Recently Issued and Adopted Accounting Standards
A discussion of recent accounting pronouncements is included in Note 2 - Basis of Presentation and Summary of Significant Accounting Policies to our unaudited consolidated financial statements included elsewhere in this Report.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
We are exposed to financial market risks, including changes in foreign currency exchange rates and interest rates.
Foreign Currency Exchange Risk
We transact business globally in multiple currencies. International revenues and foreign-denominated monetary assets and liabilities expose us to the risk of fluctuations in foreign exchange rates against the U.S. dollar. Our principal currency exposure is to the Canadian dollar, with smaller exposures to the British pound, Euro, and Japanese yen. Considering historical trends in foreign exchange rates, we determined that it was reasonably possible that adverse changes in exchange rates of 10% could be experienced. We performed a sensitivity analysis on our foreign currency exposures to estimate the potential impact of this adverse 10% change. The estimated effects on our financial position would be as follows (in thousands):
| Impact | As of September 30, 2026 | |||||||
| Foreign denominated monetary assets and liabilities | OI&E | $ | (4,390) | |||||
Interest Rate Risk
We had cash, cash equivalents, and short-term investments of $503.4 million as of September 30, 2026. We hold our cash and cash equivalents for working capital and general corporate purposes. Our cash and cash equivalents are held in cash and checking deposits, money market funds, and government securities. Our investments are held in short-term government securities. The primary objective of our investment activities is to preserve principal while at the same time maximizing yields without significantly increased risk. To achieve this objective, we invest in highly liquid securities depending on our strategic cash needs. Due to the nature of these instruments, we believe that we do not have any material exposure to changes in the fair value due to changes in interest rates. Declines in interest rates, however, would reduce our future interest income. Further, in the event of a significant decline in interest rates, we would consider taking actions to mitigate our exposure to the change.
Item 4. Controls and Procedures
Limitations on Effectiveness of Controls and Procedures
In designing and evaluating our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.
41
Disclosure Controls and Procedures
We maintain “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act that are designed to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is (1) recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms and (2) accumulated and communicated to our management, including our principal executive officer and principal financial officer, to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.
Our management, with the participation of our Chief Executive Officer and Acting Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), as of the end of the period covered by this Report. Based on such evaluation, our Chief Executive Officer and Acting Chief Financial Officer have concluded that as of September 30, 2026, our disclosure controls and procedures were effective at the reasonable assurance level.
Changes in Internal Control Over Financial Reporting
There has been no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act), during the three months ended September 30, 2026 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
42
Part II - Other Information
Item 1. Legal Proceedings
From time to time, we may become involved in legal proceedings arising in the ordinary course of business.
On October 15, 2026, a putative stockholder class action was filed in the United States District Court for the Northern District of California against the Company and certain current and former members of our senior management, captioned Fessler v. D-Wave Quantum Inc., et al. (Case No. 3:26-cv-11953). On October 20, 2026, another action was filed in the same court captioned Lawrence v. D-Wave Quantum Inc., et al. (Case No. 3:26-cv-12155). Each action (together, the “Actions”) asserts claims under Sections 10(b) and 20(a) of the Exchange Act, alleging that the Company and certain of its current and former officers made materially false or misleading statements, including about the Company’s operational and financial performance and growth. The plaintiffs in the Actions seek unspecified monetary damages and an award of costs and expenses, including reasonable attorneys’ fees and expert fees. We believe these claims are without merit, and we intend to defend the matters vigorously.
On November 2, 2026, a stockholder, Christopher Crull, filed a derivative lawsuit in the United States District Court for the Northern District of California, Crull v. Baratz, et al. (Case No. 5:26-cv-13006), against the Company (as nominal defendant only) and certain of the Company’s current and former directors and officers for, among other things, breach of fiduciary duty. The complaint alleges that the named directors and officers issued or caused the Company to issue materially false or misleading statements, including about the Company’s performance and growth and the Company’s internal controls, and that the Company suffered damages as a result. The complaint seeks, among other things, unspecified damages and reforms to the Company’s corporate governance and internal procedures.
The ultimate outcome of any litigation is uncertain and unfavorable outcomes could have a negative impact on our results of operations and financial condition. Defending such proceedings is costly and can impose a significant burden on management and team members. The results of litigation cannot be predicted with certainty, but regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.
As we are unable to determine at this time whether any loss ultimately will occur or to estimate the range of such loss, no amount of loss has been accrued by us in our financial statements as of and for the three and nine months ended September 30, 2026. If the potential loss from any claim or legal proceeding is considered probable and the amount is reasonably estimable, we will accrue a liability for the estimated loss. Legal proceedings are inherently uncertain and as circumstances change, it is possible that the amount of any accrued liability may increase, decrease or be eliminated.
There are currently no other pending or, to our knowledge, threatened legal proceedings or claims against us that, in our opinion, are likely to have a material adverse effect on our business, operating results, financial condition or cash flows.
43
Item 1A. Risk Factors
Except as set forth below, there have been no material changes from the risk factors set forth in our Annual Report on Form 10-K for the year ended December 31, 2025, as filed with the SEC on February 26, 2026 (the “2025 Form 10-K”):
Risk Factor Relating to Securities Litigation
The following risk factor in our 2025 Form 10-K is amended and restated in its entirety to read as follows:
We are, and may in the future be, subject to securities litigation, which is expensive and could divert management attention.
Companies that have experienced volatility in the market price of their stock have been subject to securities litigation, including class action litigation. In October 2026, two actions were filed against us and certain current and former members of our senior management in the United States District Court for the Northern District of California, asserting claims under Sections 10(b) and 20(a) of the Exchange Act and alleging that we and certain of our current and former officers made materially false or misleading statements, including about our operational and financial performance and growth. In November 2026, a derivative suit was filed in the same court against us and certain current and former directors and officers, alleging that the named directors and officers issued or caused the Company to issue materially false or misleading statements, including about our performance and growth and our internal controls, and that the Company suffered as a result. See Part II, Item 1, “Legal Proceedings.” We may be subject to additional securities class actions, shareholder derivative suits or other claims relating to the matters alleged or otherwise. Such litigation, regardless of its merit or outcome, could result in substantial costs and diversion of management’s attention and resources, which could have a material adverse effect on our business, financial condition, and results of operations. Any adverse determination in litigation could also subject us to significant liabilities.
Risk Factors Related to Our CHIPS Act Award
The execution of the OTA and the SIA with the Department, the receipt of funding thereunder and the Department’s ownership of an equity interest in the Company may subject the Company and its stockholders to a number of risks and uncertainties.
•The timing and amount of funding under the OTA remain uncertain. The Company’s receipt of Award funds is subject to the terms and conditions of the OTA, and there can be no assurance that the Company will receive the anticipated funds on the expected timeline, in the anticipated amounts, or at all. The Company’s receipt of funds also depends on the continued availability of appropriations from the U.S. government and the willingness and ability of the executive branch to provide the funding and support contemplated by the transactions.
•The transactions are subject to risks from changes in laws, regulations, or their interpretation, as well as shifts in federal administration and policy priorities. The legislative, judicial or executive branches of the U.S. government could determine in the future that all or a portion of the transactions were unauthorized, void or voidable. No agency or branch of the U.S. government other than the Department has made any commitment to support, or refrain from challenging, the transactions. Legal challenges, administrative rulings, litigation or geopolitical developments could materially impair funding, alter the Company’s obligations under the OTA, or otherwise adversely affect the anticipated benefits of the transactions and enforcement against a government counterparty is inherently uncertain given the defenses available to the U.S. government.
•The transactions are dilutive to existing stockholders. The issuance of the Shares to the Department at a discount to the market price of the Company’s common stock on the Award Date is dilutive to existing stockholders.
•The Department’s equity position in the Company may limit potential future strategic transactions. Although the SIA restricts the Department’s ability to vote the Shares except with respect to certain specified matters, the existence of a U.S. government equity interest, together with the Department’s contractual rights, including registration rights, may limit the Company’s ability to pursue potential future strategic transactions that could be beneficial to stockholders, including by limiting the willingness of third parties to engage in such transactions with the Company.
44
•The financial, tax and accounting treatment of the transactions is uncertain. Given the novelty and complexity of the OTA and the SIA, and the limited precedent for the accounting treatment for our transactions with the Department, the Company’s analysis of the financial, tax and accounting implications of its commitments and obligations thereunder has required the exercise of significant judgment in determining the appropriate accounting treatment. While we believe we have selected an appropriate accounting approach for these transactions in our Consolidated Condensed Financial Statements in this Form 10-Q, there are other potential approaches that, if applied, would result in materially different financial results for our third quarter of 2026 and could also materially and adversely impact our results for future periods. Refer to Note 2—“Basis of Presentation and Summary of Significant Accounting Policies—U.S. Department of Commerce Award and Securities Issuance Agreement” and Note 14—“Stockholders’ Equity—U.S. Department of Commerce Award and Securities Issuance Agreement” within the Notes to Condensed Consolidated Financial Statements for additional information. We recently voluntarily initiated a consultation with the SEC staff to seek confirmation that they do not disagree with the accounting treatment we have selected; however, this consultation has not been concluded as of the date of this filing. If the SEC staff have a different view of the appropriate accounting treatment, we may be required to materially revise our third quarter 2026 financial results, including the recognition of additional costs or losses, and our results for future periods may also be materially and adversely impacted.
•The Company may experience other adverse consequences resulting from the announcement or completion of the transactions. Given the limited number of precedents for transactions of this type involving the U.S. government taking an equity position in a company such as the Company, it is difficult to foresee all potential consequences. These may include adverse reactions from investors, employees, customers, suppliers or other business or commercial partners, as well as increased public or political scrutiny of the Company, and there may also be litigation relating to the transactions.
Any of the foregoing could have a material adverse effect on the Company’s revenue, operations, financial position, cash flows, access to financing, cost structure, competitiveness, reputation, profitability and prospects, and could exacerbate other risks discussed in the Company’s 2025 Form 10-K, Q1 2026 Form 10-Q and Q2 2026 Form 10-Q.
Risk Factor Relating to the Transfer of Our Stock Exchange Listing to Nasdaq
The following risk factor in our 2025 Form 10-K is amended and restated in its entirety to read as follows:
If we are unable for any reason to meet the continued listing requirements of Nasdaq, such action or inaction could result in a delisting of our Common Shares.
From August 5, 2022 through July 24, 2026, our Common Shares were listed on the NYSE. In July 2026, we voluntarily transferred the listing and trading of our Common Shares from the NYSE to Nasdaq, retaining the ticker symbol “QBTS”. The listing and trading of our Common Shares on the NYSE ended as of market close on July 24, 2026 and trading of our Common Shares on Nasdaq began at market open on July 27, 2026.
We were notified by the NYSE on three occasions, most recently in October 2024, that we were not in compliance with the NYSE's continued listing requirements because the average closing price of our Common Shares was less than $1.00 over a consecutive 30 trading-day period. Such notices had no immediate impact on the listing of our Common Shares, which continued to be listed and traded on the NYSE and on each occasion we regained compliance with the NYSE listing requirements during the period allowed to regain compliance.
Following the transfer of the listing of our Common Shares to Nasdaq, we are subject to similar Nasdaq continued listing requirements. If we cannot remain in compliance with the Nasdaq listing requirements, or cannot regain compliance if we become non-compliant in the future, our Common Shares will be delisted from Nasdaq. The delisting of our Common Shares from Nasdaq would likely make it more difficult for us to raise capital on favorable terms in the future, would likely have a negative effect on the price of our securities and would impair our stockholders' ability to sell or purchase our securities when they wish to do so. In the event of a delisting, actions taken by us to restore compliance with listing requirements may not allow our securities to become listed again, stabilize the market price or improve the liquidity of our securities, prevent such securities from dropping below any minimum bid price requirement or prevent future non-compliance with the Nasdaq listing requirements.
45
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
On September 8, 2026, we issued 7,095,721 Common Shares to the Department pursuant to the SIA at an aggregate price of $100.0 million, $53.6 million of which became eligible for payment as of the Award Date pursuant to the terms of the OTA and the remainder of which amount will be paid as the milestones in the OTA are achieved. The issuance of the Shares was made in reliance upon an exemption from registration under the Securities Act, pursuant to Section 4(a)(2) thereof for transactions by an issuer not involving any public offering.
Item 3. Defaults Upon Senior Securities
None.
46
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
Securities Trading Plans of Directors and Executive Officers
From time to time, some of the Company’s directors or executive officers may determine that it is advisable to diversify their investments for personal financial planning reasons or may seek liquidity for other reasons and may sell Common Shares. To effect such sales, from time to time, some of the Company’s directors or executive officers may enter into trading plans that are designed to comply with the Company’s Amended and Restated Securities Trading Policy and intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act.
During the three months ended September 30, 2026, the following executive officer of the Company adopted a “Rule 10b5-1 trading arrangement,” as such term is defined under Item 408 of Regulation S-K:
| Name and Title of Director or Executive Officer | Date of Adoption | Expiration Date of Trading Arrangement1 | Aggregate Number of Securities to be Sold | ||||||||
Up to | |||||||||||
During the three months ended September 30, 2026, none of the Company's directors or other executive officers adopted a “Rule 10b5-1 trading arrangement,” and none of the Company’s directors or executive officers modified or terminated a “Rule 10b5-1 trading arrangement” or adopted , modified, or terminated a “non-Rule 10b5-1 trading arrangement,” as such terms are defined under Item 408 of Regulation S-K.
47
Item 6. Exhibits
Exhibit No. | Description | Incorporated by Reference Exhibits | |||||||||||||||
Filer | Form | Exhibit | Filing Date | ||||||||||||||
| 10.1+ | D-Wave Quantum Inc. | 8-K | 10.1 | September 8, 2026 | |||||||||||||
| 10.2+ | D-Wave Quantum Inc. | 8-K/A | 10.2 | September 9, 2026 | |||||||||||||
| 10.3*#† | |||||||||||||||||
| 10.4# | D-Wave Quantum Inc. | 8-K/A | 10.1 | September 22, 2026 | |||||||||||||
| 10.5*+ | |||||||||||||||||
31.1* | |||||||||||||||||
31.2* | |||||||||||||||||
32.1** | |||||||||||||||||
32.2** | |||||||||||||||||
101.INS* | Inline XBRL Instance Document. | ||||||||||||||||
101.SCH* | Inline XBRL Taxonomy Extension Schema Document. | ||||||||||||||||
101.CAL* | Inline XBRL Taxonomy Extension Calculation Linkbase Document. | ||||||||||||||||
101.DEF* | Inline XBRL Taxonomy Extension Definition Linkbase Document | ||||||||||||||||
101.LAB* | Inline XBRL Taxonomy Extension Labels Linkbase Document. | ||||||||||||||||
101.PRE* | Inline XBRL Taxonomy Extension Presentation Linkbase Document. | ||||||||||||||||
104* | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). | ||||||||||||||||
* Filed herewith.
** Furnished with this report in accordance with Item 601(b)(32) of Regulation S-K, this exhibit is not deemed “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section. Such certifications will not be deemed incorporated by reference into any filing under the Securities Act, except to the extent that the registrant specifically incorporates it by reference.
# Indicates management contract or compensatory plan or arrangement.
+ Certain portions of this exhibit (indicated by “[*****]”) have been redacted pursuant to Regulation S-K, Item 601(a)(5).
† Certain portions of this exhibit (indicated by “[*****]”) have been redacted pursuant to Regulation S-K, Item 601(a)(6).
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
D-Wave Quantum Inc. | ||||||||
| November 16, 2026 | By: | /s/ Gregory Golkov | ||||||
| Gregory Golkov | ||||||||
| Acting Chief Financial Officer and Senior Vice President, Finance | ||||||||
| (Principal Financial and Accounting Officer and Duly Authorized Officer) | ||||||||
D-Wave Commercial Inc. 2650 E Bayshore Road Palo Alto, California USA 94303 www.dwavesys.com April 24, 2023 Greg Golkov [*****] Full-Time Employment Agreement This Agreement sets out the terms and conditions of your employment with D-Wave Commercial Inc. (the “Company”). If you agree with these terms and conditions, please return to us a signed copy of this Agreement. 1. Term: Subject to the Company being satisfied with your background check in its sole discretion, your employment with the Company will commence on May 01, 2023 (the “Commencement Date”) and your employment with the Company will continue under the terms and conditions of this Agreement until your employment is terminated as hereinafter provided. 2. Position and Duties: (a) Position and Duties and Responsibilities: You will be employed by the Company in the position of SVP, Finance. You will perform or fulfil such duties and responsibilities as normally or usually associated with that position and such other duties and responsibilities as may be directed from time to time by the Company in its sole discretion. You will abide by the policies, directions, and practices of the Company. In its sole discretion, the Company may alter, amend, create, or terminate policies, directions and practices. The terms and conditions of this Agreement, unless otherwise modified by the Company in writing as set out in Section 12, will continue to apply to you despite any such changes. (b) Location of Work: We have agreed that your principal place of work will be your home in [*****]. You must remain a resident of [*****] for tax and employment laws purposes and you are not authorized to relocate outside of [*****] without our consent. You must be reachable at all times during the hours of work set out in Section 2(c) by telephone, email, instant messaging applications or similar means, comply with all security procedures provided by the Company, and allow representatives of the Company to access your remote workplace as requested from time to time in order that the Company can ensure that it complies with all applicable laws and policies, including occupational health and safety regulations. You understand and agree that the Company is an international organization with an expanding business in the marketplace. Accordingly, a fundamental requirement of your position is that you will be required to regularly travel both inside and outside of North America as required by the Company in performance of your duties. In addition, from time to time as required by the Company in its sole discretion, you may be assigned new reporting relationships. Any major change in the location of your employment will be subject to expense reimbursement in the Company’s sole discretion, in accordance with the Company’s policies. (c) Scope and Hours of Work: During your employment, and subject to the Company’s business needs, you will perform at least 40 hours per week of work on such dates and times as determined by the Company in its sole discretion. While working you will devote your full time, attention and abilities to the effective and competent performance of your duties and responsibilities and you will give the Company the full benefit of your knowledge, expertise, technical skill and ingenuity. You are required to work such hours as are necessary to properly and effectively perform your duties and this may involve working hours that fall outside your usual working hours. Your base salary is paid to you in full and final compensation for all hours that you work for the Company, and you are not entitled to overtime pay or to time off in lieu.
Page 2 of 8 3. Compensation: (a) Salary: You will be paid an annual base salary of USD$300,000, payable in equal instalments on the 15th and last day of each month, less all required or permitted withholdings and remissions, according to the Company’s regular payroll schedule (the “Salary”). (b) Performance Bonus: You will be eligible to participate in the D-Wave 2023 Bonus Plan and any performance-based bonus plan in a future year that applies to permanent full-time employees of the Company who are at the level of SVP. Payment of any bonus to you is subject to the terms and conditions of the applicable bonus plan, and your on-target bonus under any applicable bonus plan will be 50% of the Base Salary, based on achievement of the corporate objectives under the applicable bonus plan, and your personal objectives set by the CEO in relation to the applicable bonus plan. The adoption of, terms of, funding of, and setting and evaluation of achievement of the corporate objectives is in the sole discretion of the board of directors of the Company (the “Board”). The setting and evaluation of the achievement of your personal objectives is in the sole discretion of the CEO. (c) Vacation Entitlement: As long as you remain a permanent employee of the Company working mainly in the United States, you will be entitled to participate in the Company’s unlimited vacation plan. Any vacation will be taken at such time or times as mutually agreed by the parties, and in compliance with the policies of the Company as amended from time to time. Failing such agreement, the Company may schedule your vacation time or times based on business considerations of the Company. Under the Company’s unlimited vacation plan, you will not accrue vacation days. Therefore, the Company will not compensate unused vacation time for any given year or upon termination of employment. (d) Medical Insurance and Other Benefits: The Company will make available to you the insured benefit plans customarily available to its US full-time employees at your level (the “Benefits”). Your participation in some of the Benefits may be mandatory in accordance with the terms and conditions of the Benefits. The terms and conditions of the Benefits, and your ability to qualify for the Benefits, will be determined by the plans or policies from time to time established, amended or purchased by the Company in its sole discretion. The Company retains the right to establish new Benefits and to eliminate, modify or alter any Benefits or benefit carriers from time to time and at any time in its sole discretion without advance notice. The terms and conditions of this Agreement will continue to apply to you despite any such changes. The Company’s obligations will not be to act as a self-insurer unless otherwise expressly stated in the terms and conditions of the applicable Benefits. The Company will, where applicable, pay premiums to an insurance carrier of its choice. All decisions regarding eligibility and coverage will be made by such insurance carrier; the Company will not bear any responsibility or liability therefore. (e) Equity Incentive Plan: Subject to approval by the compensation committee of the board of directors of D-Wave Quantum Inc. (the “Committee”), you will be eligible to participate in the 2022 Equity Incentive Plan (the “Plan”), in accordance with the terms of such Plan. After your employment with the Company has commenced, management of the Company will recommend to the Committee that you receive an equity incentive grant of D-Wave Quantum Inc. of 300,000 Restricted Share Units on such terms and conditions as determined by the Committee in their sole discretion. 4. Confidentiality: (a) Access to Confidential Information: You acknowledge that in the course of performing and fulfilling your duties and responsibilities to the Company, you may be entrusted with Confidential Information, and that the disclosure of the Confidential Information to suppliers, partners, collaborators, resellers, competitors or customers of the Company or its Affiliates or to the general public will be highly detrimental to the best interests and business of the Company and its Affiliates. “Affiliates” means any entity or corporation, directly or indirectly, through one or more intermediaries, controlling, controlled by, or under common control with the Company.
Page 3 of 8 (b) Definition: “Confidential Information” means trade secrets and information that is not generally known to the public or that would be reasonably considered confidential and proprietary to the Company, its Affiliates and their suppliers, partners, collaborators, resellers and customers, and includes but is not limited to: (i) trade secrets, know-how, concepts, ideas whether patentable or not, methods, processes, formulae, apparatus, standards, product specifications and processing procedures; (ii) revenue, costs, pricing and other financial data; (iii) any customer or business partner information (including without limitation, names, preferences, financial information, addresses or telephone numbers); (iv) all access codes, systems software applications, software/systems source and object codes, data, documentation, program files, flow charts, operational procedures, locations of operations, merchant numbers and merchant support and verification numbers; and (v) excluding wages and terms and conditions of employment, the private affairs of the Company and its Affiliates, or any other proprietary information of the Company or its Affiliates related to their business and affairs, whether acquired in the course of your employment with the Company or incidentally. (c) Exclusions: Notwithstanding the provisions of Section 4(b), “Confidential Information” does not include information or data which: (i) is in the public domain at the date of its disclosure to you, or which thereafter enters the public domain through no fault of yours or of any other person owing a duty of confidentiality to the Company or its Affiliates (but only after it enters the public domain); or (ii) was in your possession on a non-confidential basis prior to being disclosed under this Agreement as reasonably demonstrated by your written records; provided that information which comprises part of the Confidential Information will not be included within the foregoing exceptions merely because individual parts of the information were within the public domain or were within your prior possession. (d) Use and Disclosure: You acknowledge that you will receive the Confidential Information solely for the purpose of carrying out your duties and responsibilities as an employee of the Company. Except as may be specifically required in the course of carrying out such duties and responsibilities, you will not, during the term of your employment with the Company or at any time thereafter: (i) disclose any Confidential Information to any person or entity, without the prior written consent of the Company; or (ii) use or exploit, directly or indirectly, the Confidential Information for any purpose other than the proper purposes of the Company. (iii) Despite the foregoing, if you are required by law to disclose any Confidential Information, to the extent permitted by law, you will promptly notify the Company that you may be required to disclose Confidential Information and you will consult with and cooperate with the Company in any attempt to resist or narrow such disclosure or to obtain an order or other assurance that such information will be accorded confidential treatment. Notwithstanding any disclosure required by law, the Confidential Information disclosed will, for all other purposes, continue to be treated as Confidential Information under this Agreement. (iv) Nothing in this Agreement in any way prohibits or is intended to restrict or impede you from
Page 4 of 8 discussing the terms and conditions of your employment, exercising protected rights under Section 7 of the National Labor Relations Act, or disclosing or discussing information about unlawful acts in the workplace, such as harassment or discrimination or any other conduct that you have reason to believe is unlawful. (e) Return: Upon the termination of your employment with the Company for any reason, or upon the written request of the Company at any time, you will return immediately to the Company all Confidential Information then in your possession or under your control, including all written information, tapes, discs or memory devices and copies thereof including, without limitation, all papers, drawings, notes, notebooks, correspondence, records, reports, lists, photographs, memoranda, manuals, specifications, designs, devices and documents, and any other material on any medium in your possession or control pertaining to the Company. You will also return any computers, phones, keys, pass cards, identification cards or other property belonging to the Company. 5. Corporate Opportunities and Intellectual Property: (a) Opportunities: Any business opportunities related to: (i) the current business or prospective business of the Company or its Affiliates; (ii) any of the Confidential Information or any of the Property (as defined below); or (iii) any work performed by you for the Company; which become known to you during the period of your employment with the Company must be promptly and fully disclosed and made available by you to the Company, and you agree not to take or omit to take, without the prior written approval of the Company, any action if the result would be to divert from the Company or its Affiliates any such opportunity. (b) Property Ownership: You acknowledge and agree that all right, title and interest in and to any information, documents, drawings, plans, models, works, trade secrets, inventions, discoveries, methods, improvements, research materials, designs, algorithms, user interfaces, application programming interfaces, software and databases, including all Confidential Information and including all intellectual property rights associated therewith, that: (i) relate to the Company’s or its Affiliates’ business, as it may be conducted from time to time, and is made or conceived directly or indirectly by you during the course of your employment, whether or not conceived or made during your regular working hours and whether or not you are specifically instructed to make or develop the same and whether made solely, jointly or in combination with others; (ii) are made or conceived directly or indirectly by you during the course of your employment and during your regular working hours, whether or not you are specifically instructed to make or develop the same or whether made solely, jointly or in combination with others; or (iii) are made or conceived directly or indirectly by you during the course of your employment and using the Company’s or its Affiliates’ tools and equipment, whether or not conceived or made during your regular working hours and whether or not you are specifically instructed to make or develop the same and whether made solely, jointly or in combination with others; (collectively the “Property”), will be for the benefit of the Company or its Affiliates, as applicable, and will be considered to have been made under and by virtue of this Agreement and will immediately become the property of the Company or its Affiliates, as applicable. Any invention described in a patent application filed by or on behalf of you, or which is disclosed to third parties by you within one (1) year after terminating your employment with the Company which relates to your work with the Company, is rebuttably presumed to have been conceived or made during the period of your employment by the
Page 5 of 8 Company using the trade secrets or other intellectual property rights of the Company or its Affiliates, and you hereby assign and agree to assign the invention and all rights therein to the Company as provided by this Agreement, including any application or registration related to such invention. The assignment or offer to assign set forth in this Section 5(b) does not apply to an invention in relation to which you can clearly show by corroborating evidence that such invention was made without the use of the Company’s or its Affiliates’ trade secrets or other intellectual property rights and was made entirely on your own time, without the use of Company’s or its Affiliates’ equipment, supplies or facilities, unless (a) the invention relates (i) directly to the business of the Company or its Affiliates, or (ii) to the Company’s or its Affiliates’ actual or demonstrably anticipated research or development, or (b) the invention results from any work performed by you for the Company or its Affiliates. (c) Assignments: You hereby assign and agree to assign to the Company your entire right, title and interest in and to any and all of the Property and to all letters patent, design patents, industrial designs, copyright, mask works, trade-marks, trade secret rights, and all other intellectual property rights, and all applications therefor which may be or may have been filed on the Property by or for you or in your name, or which may have been issued to you or for your benefit, whether filed or issued in the United States or any other country whatsoever, including the right to claim priority thereof, to file directly in the Company’s own name, to have patents grant in the Company’s own name, and to pursue damages for infringement of any such rights, including for past infringement. You further agree to execute any papers evidencing such assignment, including executing counterpart or short form assignment documents, and to fully cooperate as may be requested by the Company, at the Company’s own expense, in evidencing such assignment and in securing intellectual property rights in the Property. (d) Moral Rights: You forever waive and release in favor of the Company and its Affiliates any right, title or interest you have or may have in and to the Property including, without limitation, any right to claim authorship or anonymity, any right to restrain or claim damages for any modification, alteration or deletion of the Property or any part thereof, any right to restrain the use or reproduction of the Property, and any right to use or reproduce the Property, in each case, in any context and in connection with any product, service, cause or institution, and any right or benefit in law known as “moral” rights or any similar law anywhere in the world and all rights under the Canadian Copyright Act. (e) Publications: You will not publish or disclose, or assist others to do so, any particulars of the Property or of any Confidential Information to any person or entity without the prior written consent of the Company. (f) Removal of Property: All records, files, source or object codes, data, materials, tapes, documents, equipment, drawings, plans, models and the like relating to the Confidential Information or the Property is and will remain the sole and exclusive property of the Company or its Affiliates, as applicable. Except as authorized by the Company, you will not remove physically, electronically or in any other manner whatsoever from the premises of the Company or store or permit to be stored in any location other than the premises of the Company the Property or the Confidential Information or any records, files, source or object codes, data, materials, tapes, documents, equipment, drawings, plans, models and the like relating to the Confidential Information or Property. (g) Third Party Confidential Information and Conflicts of Interest: The Company relies on its Confidential Information and Property and respects the confidential information and property of others. For this reason, the Company does not want, does not need and will not accept the confidential information or property of any third party, including but not limited to any of your former employers. You represent and warrant to the Company that by entering into this Agreement with the Company you will not be in breach of any laws or agreement with any third party nor will you be in a position of conflict of interest to any third party. In particular, you represent and warrant to the Company that you are not subject to any law, agreement with or other obligation that would restrict your ability to perform your employment duties to the Company or that would in any way impair the Company’s ownership of the Confidential Information or Property. During your employment with the Company, you are strictly prohibited from using or disclosing to the Company any information that you obtained in confidence from a third party. You understand and agree that any breach of this Section, regardless of the materiality of the breach, will constitute immediate grounds for termination of your employment for Initial Here
Page 6 of 8 cause. 6. Restrictive Covenant: (a) The parties acknowledge that the Company’s and its Affiliates’ business is highly competitive and that in the course of your employment you will be privy to Confidential Information and other proprietary information concerning the Company’s and its Affiliates’ business and that the Company’s and its Affiliates’ business would be vulnerable to competition from you. (b) Accordingly, you will not during the term of your employment with the Company and following the date that your employment with the Company ceases (regardless of who initiated the termination and whether the termination was with or without cause), either individually or in partnership, or in conjunction in any way with any other persons, whether as principal, agent, consultant, shareholder, guarantor, creditor, or in any other manner whatsoever: (i) other than in the performance of your duties and responsibilities, use any of the Company’s and its Affiliates’ trade secrets for any reason without the express written permission of the Company, including to: (1) engage in, carry on or otherwise be concerned with or have any interest in, or advise, lend money to, guarantee the debts or obligations of, permit your name, or any part thereof, to be used or employed by any person, firm, association, syndicate or corporation engaged in or concerned with a business competitive with that of the Company or its Affiliates; or (2) solicit, interfere with or endeavor to entice away from the Company or its Affiliates, accept any business from or the patronage of or enter into the employment of or render any service to, sell to or contract or attempt to contract with, any person, firm, or corporation who was, during the term of your employment, a customer or supplier of the Company or its Affiliates, or a prospective customer or supplier of the Company or its Affiliates; or (ii) for a one (1) year period following the termination of your employment with the Company, directly solicit or induce or attempt to solicit or induce any person who was employed by the Company or its Affiliates on the date of the termination of your employment, to terminate his or her employment with the Company or its Affiliates or to commence an employment or other business relationship with another entity. (c) The parties agree that the foregoing provisions are reasonable and necessary in order to protect the interests of the Company and its Affiliates. (d) You agree and acknowledge that this covenant is given for good and valuable consideration (receipt of which is hereby acknowledged) and that by reason of your unique knowledge of and association with the business of the Company and its Affiliates, the scope of this covenant as to both time and area is reasonable and commensurate with the protection of the legitimate interests of the Company and its Affiliates. Section 6 of this Agreement applies regardless of the reason for your cessation of employment from the Company, and is severable from the other provisions of this Agreement. (e) The parties agree that if a court of competent jurisdiction will limit, restrict or otherwise change the time period or the types of business referred to in this Section, then the limited, restricted or changed time period or types of business determined by such a court will, for the purposes of this Section 6, be deemed to be the original time period and/or types of business referred to in such Sections as if they were the original time period and business set out herein. 7. Resignation: You can resign from employment with the Company by providing to the Company two (2) weeks’ prior written notice of your resignation. The Company may elect, in its sole discretion, to not require that you attend work for any portion of this two (2) week notice period in which case your Salary would continue
Page 7 of 8 for the balance of the notice period and your benefits would, at the option of the Company, cease effective on your last day of work. 8. Employment at Will: Your employment with the Company is “at will” according to the laws of the State of New Jersey. As an at-will employee, you or the Company may terminate your employment at any time with or without cause and with or without notice except where applicable United States federal, State of New Jersey or local law provides otherwise. The Company also has sole discretion to modify the terms and conditions of your employment. No representative of the Company, other than the CEO has the authority to change the “at- will” status of any employee, and in order to be effective, the change must be in writing. 9. Irreparable Harm: You acknowledge and agree that a breach of any of the covenants of this Agreement by you may not be adequately compensated for by monetary award, and may cause irreparable harm to the Company and its Affiliates. Accordingly, you agree that in addition to all of the remedies available to the Company and its Affiliates at law or in equity, including the right to seek recovery of damages, the Company and its Affiliates will be entitled as a matter of right to apply for equitable relief (including without limitation, injunctive relief) in any court of competent jurisdiction, enjoining any threatened or actual breach, to ensure your compliance with the provisions of this Agreement. 10. Assignment and Enurement: You may not assign this Agreement, or any part of this Agreement or any of your rights under this Agreement, without the prior written consent of the Company. The Company may assign this Agreement to any other entity at any time in its sole discretion. This Agreement enures to the benefit of and is binding upon you and the Company and the respective heirs, executors, administrators, successors and permitted assigns. 11. Severability: If any provision or portion of this Agreement is determined to be invalid or unenforceable for any reason, then that provision or portion will be severed from this Agreement unless otherwise provided. The rest of this Agreement will remain in full force and effect. 12. Entire Agreement: This Agreement contains the whole agreement between you and the Company with respect to your employment with the Company, and there are no representations, warranties, collateral terms or conditions, express or implied, other than as set forth in this Agreement. This Agreement supersedes all prior agreements, negotiations, discussions, undertakings, representations, warranties and understandings, whether written or oral, express or implied, statutory or otherwise, between you and the Company. You hereby waive any right to assert a claim in tort based on any pre-contractual representations, negligent or otherwise, made by the Company. You also hereby confirm that you have not been induced to enter into this Agreement by any prior agreement, negotiation, discussion, undertaking, representation, warranty, or understanding, whether written or oral, express or implied, statutory or otherwise, between you and the Company. No change or modification of this Agreement will be valid unless it is in writing and executed by both parties. The terms and conditions of this Agreement will govern your employment with the Company, regardless of the length of employment or any changes to your position, compensation, title and regardless of whether such change is material or otherwise. 13. Notice: Any notice required or permitted to be given hereunder must be in writing and will be sufficiently given or made if delivered or sent by email or by registered mail to the address of the parties set out on page 1 hereof. Any notice so given will be deemed to have been given and to have been received on the day of delivery if it is a business day and otherwise on the next succeeding business day or, if mailed, on the third business day following the mailing thereof (excluding each day during which there exists any interruption of postal services due to strike, lockout or other cause). Addresses for notice may be changed by giving notice in accordance with this Section. 14. Non-waiver: No failure or delay by you or the Company in exercising any power or right under this Agreement will operate as a waiver of such power or right. Any consent or waiver by you or by the Company to any breach or default under this Agreement will be effective only in the specific instance and for the specific purpose for which it was given. 15. Survival of Terms: The provisions of Sections 4 to 18 of this Agreement will survive the termination of your employment and this Agreement.
Page 8 of 8 16. Collection and Use of Personal Information: You acknowledge that the Company will, and hereby consent to the Company collecting, using and disclosing personal information about you where reasonably necessary for security, employment and business purposes in accordance with applicable legislation and any privacy policy of the Company that may be in effect from time to time. 17. Further Assistance and Independent Legal Advice: The parties will execute and deliver any documents and perform any acts necessary to carry out the intent of this Agreement. You also represent and warrant to the Company and acknowledge and agree that you have been provided an opportunity to seek and were not prevented nor discouraged by the Company from seeking independent legal advice prior to signing and delivering this Agreement. 18. Governing Laws: This Agreement will be construed in accordance with and governed by the laws of the State of New Jersey (without reference to its conflict of law principles), and the courts of the State of New Jersey will have exclusive jurisdiction over any dispute arising from or in any way related to this Agreement. THE PARTIES have executed this agreement as of the date written above. D-WAVE COMMERCIAL INC. Per: VICTORIA BRYDON I acknowledge and accept the terms and conditions of my employment with the Company as set out above. GREG GOLKOV /s/ Victoria Brydon /s/ Greg Golkov
Exhibit 10.5 TECHNOLOGY AS A SERVICE AGREEMENT This Technology as a Service Agreement (the “Agreement”) is entered into effective as of October 10, 2026 (“Effective Date”) by and between SkyWater Technology Foundry, Inc., a Delaware corporation with offices located at 2401 East 86th Street Bloomington, MN 55425 (“SkyWater”) and D-Wave Systems Inc., a Canadian corporation, with offices located at 3033 Beta Ave, Burnaby, British Columbia, V5G 4M9 Canada (“Customer” or “D-Wave”) (each a “Party”, collectively the “Parties”). Background: The Parties desire to put terms and conditions in place related to SkyWater’s development and manufacture of products and/or provision of services for Customer. The Parties agree as follows: 1. DEFINITIONS 1.1. “Affiliate” means any entity which controls, is controlled by, or is under common control with the Party in question. For purposes of this definition, “control” when used with respect to any party, means ownership of at least 50% of the voting securities or the power to direct the management and policies of such party, directly or indirectly, whether through the ownership of voting securities, by contract, or otherwise. 1.2. “Advanced Technology Services” means SkyWater’s semiconductor foundry, manufacturing, development, and other technical services, including the development and manufacture of Products, as more specifically defined in an applicable Exhibit. 1.3. “Background IP” means all Intellectual Property owned or licensed by a Party (a) before commencement of any Advanced Technology Services; or (b) conceived, invented, developed, or improved independently of this Agreement or any applicable Exhibit, whether before or during the Term. 1.4. “Change of Control” means, with respect to a Party, any transaction or series of related transactions resulting in (a) the acquisition by any third party of direct or indirect control of a Party, including through a merger, acquisition, consolidation, reorganization, or similar transaction; or (b) the sale or transfer of all or substantially all of its assets or business. 1.5. “Confidential Information” means confidential or proprietary information of a Party or its Affiliates. Without limiting the generality of the foregoing, Confidential Information includes enterprise software, documents, plant, equipment, Customer technology, products and manufacturing processes, product plans, ideas, inventions, designs, costs, prices and names, finances, marketing plans, business opportunities, personnel, studies, experiments, prototypes, formulae, research, development or know- how, and financial information concerning SkyWater’s and Customer’s customers, suppliers, and their respective products and/or services and proposed products and/or services. 1.6. “Control Plan IP” means Intellectual Property pertaining to the control plans and their design, monitoring tools, and techniques used to ensure a Product meets applicable specifications and other requirements. 1.7. “Customer Control Plan IP” means Control Plan IP developed from Customer’s Background IP, including control plans, designs, specifications, methodologies, tools and techniques. Customer Control Plan IP may include, but is not limited to: (a) Cryogenic testing methodologies; (b) Superconducting device characterization methods including noise properties; and (c) Any test flows or specifications created or defined by Customer.
2 SkyWater Confidential and Proprietary Rev. 06.2024 1.8. “Customer Equipment” means and includes any equipment and related software on the Line owned by Customer, including any upgrades thereto. 1.9. “Customer Property” means any tangible property owned by Customer and utilized or stored by SkyWater but does not include Customer Equipment. 1.10. “Customer Unit Process IP” means: (a) any Unit Process IP that constitutes Superconducting Technology; (b) any Unit Process IP provided primarily by or on behalf of Customer, or primarily developed by or for Customer by any third party (other than SkyWater, its Affiliates, or their Representatives), and incorporated into or used in the performance of Advanced Technology Services; and (c) any Unit Process IP developed in connection with the Advanced Technology Services using Customer Equipment, to the extent such assets are required for the development of such Unit Process IP. For clarity, any Improvements to SkyWater Unit Process IP that meet the criteria described in subsections (a) through (c) above shall constitute Customer Unit Process IP and shall be owned by Customer notwithstanding Section 8.3 or any characterization as an Improvement under this Agreement. 1.11. “Exhibit” means any document labeled as an exhibit and its attachments (e.g. appendices) pursuant to which SkyWater provides products and services to Customer and that is executed by both Parties and governed by this Agreement. 1.12. “Improvements” means any modifications, enhancements, developments, refinements, adaptations, or derivatives of any Intellectual Property. 1.13. “Intellectual Property” means any and all rights of the following types, which may exist or be created under the laws of any jurisdiction in the world, whether registered or unregistered, and whether now existing or later developed or improved upon: (i) patents, industrial property, and applications for patents and industrial property; (ii) trademarks, service marks, trade dress, rights of publicity, rights in trade names, corporate names, and similar rights, including all registrations and applications for registration of the foregoing and all goodwill associated therewith; (iii) rights associated with works of authorship or mask works, including copyrights, mask work rights, and registrations and applications for registration thereof, regardless of the medium of fixation or means of expression; (iv) all rights in technical information, trade secrets, formulas, prototypes, specifications, directions, instructions, test protocols, procedures, results, studies, analyses, raw material sources, data, manufacturing data, formulation or production technology, conceptions, ideas, innovations, discoveries, inventions, processes, methods, materials, machines, devices, formulae, equipment, enhancements, modifications, technological developments, techniques, systems, tools, designs, drawings, plans, software, documentation, data, programs, and other know-how (whether documented or undocumented), knowledge, information, skills, and materials; and (v) any other proprietary rights in or to technology anywhere in the world. 1.14. “Intended Use” means Customer’s intended use of the Products as expressly stated under the applicable Exhibit. 1.15. “Line” means SkyWater’s product manufacturing line at the Premises, or any SkyWater designated alternative or substitute site thereto. 1.16. “Loss” means resulting loss, cost, expense or damage, including reasonable attorney’s fees and other legal expenses.
3 SkyWater Confidential and Proprietary Rev. 06.2024 1.17. “Personnel” means the employees, contractors, and agents of a Party. 1.18. “Pre-Existing Project IP” means Intellectual Property developed under the Existing Agreement (as defined below), prior to the Effective Date of this Agreement. For clarity, Pre-Existing Project IP does not include any Intellectual Property developed independently of the Existing Agreement or any Intellectual Property developed after the Effective Date of this Agreement. 1.19. “Premises” means SkyWater’s facilities relevant to this Agreement. 1.20. “Procedure" means SkyWater's then-current standard operating procedures, including the standard operating manual, specifications, and other documentation. 1.21. “Process Flow IP” means Intellectual Property pertaining to the aggregation or whole sequencing of unit process steps to create a Product (for clarity, Process Flow IP is the aggregation of individual processing steps, but not the specific individual process steps themselves). 1.22. “Product Design IP” means Intellectual Property pertaining to the design and layout of a Product, including mask designs, device design, reticle layout, and related circuit schematics. 1.23. “Product” has the meaning set forth in the applicable Exhibit, and if not defined there, (i) with respect to Advanced Technology Services, means a development or pre-production product (e.g. wafer), and (ii) with respect to Production Services, means a product in volume production (e.g. wafer). 1.24. “Production Services” means SkyWater’s services related to Products in volume production, as more specifically defined in the applicable Exhibit. 1.25. "Purchase Order” or “PO” means a firm order issued by Customer for SkyWater products and services, where “firm” means a binding commitment once accepted by SkyWater, except as otherwise agreed in writing by the Parties. 1.26. “Representatives” means with respect to each Party, its and its’ Affiliates’ directors, managers, officers, employees, agents, contractors, co-investors, lenders, financing sources, or advisors (including, without limitation, lawyers, accountants, auditors, consultants, bankers, insurance providers/brokers, and financial advisors). 1.27. “Restricted Field” means the design, development, manufacture or commercialization of products or services that are intended for, or reasonably expected to be used in, or competitive with superconducting computing technologies, including any technologies used to enable, control, characterize, test, operate, or manufacture such technologies. SkyWater may conduct internal development work provided that such work does not involve the use of Customer-owned Intellectual Property or Customer Confidential Information in a manner that would circumvent the restrictions set forth in this Agreement. 1.28. “Standard Commercial Price List” means the then-current SkyWater document which details the fees, rates, and other charges applicable to SkyWater’s products and services. 1.29. “SkyWater Control Plan IP” means all Control Plan IP other than Customer Control Plan IP. 1.30. “SkyWater Unit Process IP” means all Unit Process IP other than Customer Unit Process IP. 1.31. “Superconducting Technology” means technology uniquely and primarily responsible for enabling the device properties or performance of a superconducting end Product, which may include but is not limited to superconducting materials, Josephson junctions, superconducting wiring and wiring
4 SkyWater Confidential and Proprietary Rev. 06.2024 interconnects, coherence-enhancing dielectric materials and interface engineering, and related superconducting circuit elements. Superconducting Technology excludes generally applicable semiconductor fabrication process modules and manufacturing process control, except when this technology has been modified to uniquely and primarily enable such superconducting properties or performance. 1.32. “Unit Process IP” means Intellectual Property pertaining to (i) the individual and in-between process steps performed to develop and manufacture a Product; and (ii) the recipes, tools, configurations, settings, and materials involved to process and manufacture a Product. 2. SCOPE 2.1. Pursuant to the terms and conditions of this Agreement, the Parties may enter into one or more Exhibits which specifically describe the products and services to be provisioned by SkyWater. SkyWater will utilize a phase-gate Product development-to-production approach pursuant to Procedures to determine a Product’s transition from development to volume production. SkyWater will communicate completion of such transition by specifically notifying Customer in writing (email being sufficient), or by accepting Purchase Orders for Products in volume production. 2.2. In the event of any conflict between this Agreement and any Exhibit, the terms and conditions of the applicable Exhibit will control. This Agreement applies to all business transactions between Customer and SkyWater related to the purchase or procurement of SkyWater’s products and services, even if the Customer or SkyWater do not refer explicitly to this Agreement in their business communication, including but not limited to any Purchase Orders issued. In the event of conflict between any such transactional documents between the Parties and this Agreement, the terms of this Agreement will control. 2.3. This Agreement supersedes and replaces entirely the Agreement for Semiconductor Line Operation between the Parties dated December 23, 2012, as subsequently amended (the “Existing Agreement”). For clarity, upon execution of this Agreement, the Existing Agreement shall automatically terminate and be of no further force or effect. 3. SECURITY 3.1. Security. 3.1.1. Customer acknowledges that security of SkyWater’s Premises, systems, and networks are of paramount importance. Customer Personnel are not permitted to access any area except as expressly authorized by SkyWater. Customer Personnel shall wear a security badge at all times while on SkyWater’s Premises. Further, Customer agrees to at all times comply with SkyWater’s policies and procedures applicable to Customer’s access to and use of SkyWater Premises, systems, and network. In the event that SkyWater needs to restrict or limit Customer Personnel’s previously authorized access to its Premises, systems or networks, it will use commercially reasonable efforts to provide Customer with advance written notice (email being sufficient), except in cases of emergency where immediate restriction is necessary for safety, security, or legal compliance reasons. 3.1.2. In the event any Customer Personnel has intentionally gained unauthorized access to any portion of SkyWater’s Premises, systems, or networks, or improperly removed, used, or disclosed any Confidential Information, such persons may be immediately barred from all SkyWater Premises, systems, and networks, and such persons’ actions will be deemed a material breach of this Agreement by Customer. SkyWater is not liable for any failure to perform under this Agreement to the extent caused by operation of this Section 3.1.2. 4. LINE OPERATION 4.1. Line Operation. SkyWater operates the Line in accordance with the Procedures.
5 SkyWater Confidential and Proprietary Rev. 06.2024 4.2. Safety. Customer acknowledges safety is of utmost importance to SkyWater. Customer Personnel must follow SkyWater’s health and safety practices and instructions while on the Premises. This includes, but is not limited to, chemical handling, lock-out-tag-out, tool, and use of safety gear. All chemicals brought on to the Premises must be approved by SkyWater’s in accordance with its environmental health and safety policies. 4.3. Line Management. SkyWater’s site operations management exercises day-to-day managerial authority over the Line, including without limitation authority over the allocation of Line activities, within the parameters established by this Agreement. Subject to the other provisions of this Agreement, SkyWater’s site operations management also oversees all aspects of the operation, development, and planning of the Line. 5. CUSTOMER PROPERTY AND EQUIPMENT 5.1. Customer Property. 5.1.1. If any Customer Property stored by SkyWater is not utilized by SkyWater in relation to this Agreement for six (6) months or such other period as mutually agreed to in writing by the Parties, SkyWater shall provide Customer with written notice. Following such notice, Customer shall have up to fourteen (14) business days to provide disposition instructions. If Customer does not provide instructions within that period, SkyWater may at its sole discretion (i) upon providing Customer at least one (1) week advance notice, ship the Customer Property to Customer at Customer’s expense, or (ii) begin invoicing Customer for storage costs at the then-current rate. Customer may choose to have the Customer Property destroyed by SkyWater, at Customer’s expense, instead of having it shipped or incurring storage fees pursuant to the preceding sentence. If SkyWater determines that any Customer Property is scrap, SkyWater shall provide Customer with written notice of the determination and reasonable detail supporting it. Customer shall have up to fourteen (14) business days from receipt of notice to provide disposition instructions. If Customer does not provide instructions within that period, SkyWater may elect (at Customer’s expense) to either (i) destroy the scrap Customer Property per SkyWater Procedure, or (ii) upon providing Customer at least one (1) week advance notice, ship the scrap Customer Property to Customer. SkyWater shall not ship, destroy or begin charging storage fees for any Customer Property without first providing Customer the above notice and opportunity to respond. 5.1.2. Upon expiration or termination of this Agreement, SkyWater shall return to Customer or, at Customer’s direction and expense, securely destroy all Customer Property in its possession or control in accordance with the applicable Exhibit or any written return or destruction procedures mutually agreed by the Parties. SkyWater shall provide written confirmation of such return or destruction upon Customer’s request. Unless otherwise agreed, returned Customer Property shall be in substantially the same condition as received, except for ordinary wear and tear. 5.1.3. Customer shall bear all costs associated with ownership and insurance of Customer Property, including sales, use, property, and other taxes imposed on or otherwise attributable to Customer Property. SkyWater has no responsibility for loss or damage to any Customer Property unless such loss or damage is directly caused by SkyWater’s negligent act or omission, or failure to exercise reasonable care. 5.2. Customer Equipment. 5.2.1. If SkyWater agrees to allow installation of Customer Equipment on SkyWater’s Premises, Customer and SkyWater shall in good faith negotiate any terms and conditions not otherwise covered by this Agreement or an applicable Exhibit for the fees, installation, use, and deinstallation of Customer Equipment.
6 SkyWater Confidential and Proprietary Rev. 06.2024 6. PAYMENT 6.1. Payments. 6.1.1. The prices, fees, and costs to be paid by Customer are set forth in the applicable Exhibit. Except as specifically stated in the Exhibit, the payment and delivery terms are as described in Section 6.3 below. SkyWater’s Standard Commercial Price List is SkyWater’s Confidential Information and subject to change by SkyWater from time to time, provided that SkyWater shall provide written notice (email sufficient) to Customer of any changes to its pricing with respect to any pricing currently in effect under the Agreement. Except as provided under this Agreement, any such changes shall apply prospectively and shall not affect any Exhibits and/or Purchase Orders accepted prior to the effective date of the change. Upon Customer’s written request, SkyWater will provide a copy of the Standard Commercial Price List subject to the confidentiality obligations of this Agreement. 6.2. Taxes. Customer is responsible for and shall pay all customs, duties, and except for taxes based on SkyWater’s income, all sales, use, excise, ad valorem, VAT, or other taxes attributable to SkyWater’s provision of the services and products under this Agreement. If Customer claims exemption from tax, (i) Customer shall provide SkyWater a valid certificate of tax exemption prior to delivery of the applicable products and services, and (ii) Customer is responsible for defending claims or audits from any taxing authority, and shall indemnify SkyWater against any fees, penalties, and/or taxes due and assessed as a result of the exemption certificate being invalid, inaccurate or not acceptable by the relevant taxing authority. For clarity, SkyWater shall remain responsible for its own tax audits except to the extent the audit relates specifically to Customer’s claimed exemption. 6.3. Payment and Delivery Terms. 6.3.1. Customer will be invoiced as set forth in the applicable Exhibit. In the event invoice frequency is not specified under the applicable Exhibit, SkyWater will invoice Customer on a monthly basis. 6.3.2. All payments required hereunder by Customer shall be paid within thirty (30) days of the applicable invoice date. 6.3.3. Products and other material shipped under the Agreement will be delivered “Ex Works” point of shipment, as defined in the International Chamber of Commerce’s Incoterms 2020. SkyWater will make goods available at their premises. Customer bears all costs and risks from this point forward, including loading, transport, export/import clearance, and applicable duties. 7. PERSONNEL 7.1. Status of Personnel. Each Party is responsible for its Personnel’s compliance with the obligations of this Agreement, and further undertakes and agrees that it will impose on its Personnel, by contract or otherwise, the obligation to comply with this Agreement. 8. INTELLECTUAL PROPERTY 8.1. Ownership. With the exception of each Party’s respective Background IP, the ownership structure below will apply to all Intellectual Property developed as part of this Agreement or any applicable Exhibit without regard to which Party (or such Party’s Personnel) created, invented, or otherwise generated such Intellectual Property: Background IP Except as expressly agreed by the Parties in writing, nothing will change or transfer either Party’s ownership or rights in any Background IP.
7 SkyWater Confidential and Proprietary Rev. 06.2024 Unit Process IP SkyWater owns all SkyWater Unit Process IP and Customer owns all Customer Unit Process IP. Control Plan IP SkyWater owns all SkyWater Control Plan IP, and Customer owns all Customer Control Plan IP. Process Flow IP Customer owns all Process Flow IP. Product Design IP Customer owns all Product Design IP. 8.2. Pre-Existing Project IP. Nothing in this Agreement shall operate to transfer ownership of any Intellectual Property existing prior to the Effective Date, including any Pre-Existing Project IP, and no such Intellectual Property shall be deemed assigned, transferred, or re-assigned by implication, estoppel or otherwise. (a) To the extent any Pre-Existing Project IP owned or controlled by SkyWater is incorporated into, used in, or reasonably necessary for the use, reproduction, or commercialization of any Customer Unit Process IP, Products, such Pre-Existing Project IP shall be licensed to Customer in accordance with Section 8.5, solely to the extent necessary to enable such use. (b) To the extent any Pre-Existing Project IP owned or controlled by Customer is used by SkyWater in, or reasonably necessary for, the performance of the Advanced Technology Services under this Agreement, Customer grants to SkyWater a worldwide, non-exclusive, non- transferable, non-sublicensable, revocable (in connection with termination of this Agreement), fully paid-up, royalty-free license to such Pre-Existing Project IP solely to the extent necessary for SkyWater to perform its obligations under this Agreement during the Term. For clarity, SkyWater shall not use Customer-owned Intellectual Property or Customer-owned Pre-Existing Project IP, or any derivatives thereof, other than to perform its obligations under this Agreement. 8.3 Improvements. Except as expressly stated otherwise in this Agreement, any Improvements made in connection with this Agreement to a Party’s Intellectual Property (whether made by Customer, SkyWater, the Parties together, or otherwise) shall be owned exclusively by that Party. For clarity, ownership and classification of Intellectual Property shall be determined in accordance with the applicable definitions and ownership provisions of this Agreement, and nothing in this Section 8.3 shall modify such ownership or classification. 8.4 Further Assurances. The Parties agree to obtain or execute any documents, paperwork, signatures, assignments, and the like needed to perfect or effectuate either Party’s rights in Intellectual Property as contemplated by this Agreement. Each Party further agrees to provide reasonable assistance to the other Party as needed to perfect or effectuate such rights. Any additional Intellectual Property ownership rights between the Parties that are not set forth in this Agreement shall be specified in the applicable Exhibit. 8.5 Customer’s License. SkyWater grants to Customer a worldwide, non-exclusive, perpetual, royalty-free, irrevocable, non-transferable, and sublicensable, fully paid-up license to SkyWater Intellectual Property (as specified in Section 8.1), used to manufacture, incorporated into, or otherwise provided in connection with the Products and/or under this Agreement, to the extent necessary for Customer and its Affiliates to use, test, evaluate, offer to sell, sell, import, integrate, and service the Products and to carry out the activities set forth under this Agreement.
8 SkyWater Confidential and Proprietary Rev. 06.2024 During the Agreement Term, Customer may request a broader license to SkyWater’s Intellectual Property described in this Section 8.5, and the Parties shall negotiate in good faith to determine the license scope, fees, and additional terms and conditions to govern such broader license. 8.6 SkyWater’s License. Customer grants to SkyWater a worldwide, non-exclusive, perpetual, irrevocable, sublicensable, non-transferable, fully paid-up, royalty free license to all Customer Intellectual Property related to the Products and this Agreement solely to the extent necessary for SkyWater to carry out the activities set forth under this Agreement. Customer grants to SkyWater a worldwide, non- exclusive, perpetual, irrevocable, non-transferable, fully paid-up, royalty free license to all Customer Unit Process IP developed under this Agreement, solely for internal development purposes directly related to the Advanced Technology Services and for providing products or services to third parties outside the Restricted Field, provided SkyWater does not disclose Customer’s Confidential Information. For clarity, no license is granted to SkyWater under any Product Design IP, Process Flow IP, or Customer Background IP. These licenses granted under this Section shall be irrevocable, except in the event of Customer’s rightful termination of the Agreement for SkyWater’s uncured material breach of this Agreement. For the avoidance of doubt, SkyWater shall not, under any circumstances, use any Customer-owned Intellectual Property, or any Improvements thereof, within the Restricted Field, except as expressly permitted by Customer in writing or as set forth in Schedule A. SkyWater shall not structure, characterize or provide products or services in a manner that has the effect of violating the Restricted Field limitations set forth in this Agreement. Any additional Intellectual Property licenses granted by one Party to another not set forth in this Agreement shall be specified in the applicable Exhibit. 8.7 No Implied Licenses. Except as specifically provided under this Agreement, no licenses or other rights under any of either Party’s Intellectual Property rights are granted or implied under this Agreement. 8.8 Schedule A. To assist SkyWater in educating its Personnel and to clearly articulate each Party’s rights, the Parties have prepared a non-exhaustive list of Intellectual Property rights existing as of the Effective Date, which has been attached as Schedule A to this Agreement. The Parties shall cooperate in good faith to regularly review and update Schedule A to reflect newly developed Intellectual Property and any agreed ownership classifications. For the avoidance of doubt, Schedule A does not determine or alter ownership of any Intellectual Property or restrict SkyWater-owned Intellectual Property or rights otherwise expressly granted under this Agreement. “No” grants no additional rights. “Yes” extends the license in the second sentence of Section 8.6 to the applicable Customer-owned recipes, whenever developed and included in Schedule A, for SkyWater to provide products or services to third parties within or outside the Restricted Field, subject to the applicable “Note” specified in the table in Schedule A. Failure to identify any Intellectual Property in Schedule A shall not modify or limit ownership otherwise determined under this Agreement. 9 INDEMNIFICATION 9.1 Indemnity by SkyWater. SkyWater shall indemnify, defend, and hold harmless Customer against and from any third party claim, action, allegation, or proceeding brought against Customer and any resulting Loss, against or required to be paid by Customer or any Affiliate of Customer or any of their Personnel, which results from (i) a claim that SkyWater’s Intellectual Property used in manufacturing the Products or the provision of Advanced Technology Services under this Agreement constitutes an infringement or misappropriation of any Intellectual Property right of a third party, or (ii) any claims resulting from grossly negligent or intentionally wrongful act or omission of SkyWater or any SkyWater Personnel. However, SkyWater has no obligation to indemnify Customer for any claim arising from (i) compliance with Customer’s designs, specifications, or instructions, (ii) modification or combination of Products with any technology, products, or services not provided by SkyWater or its Affiliates, or (iii) use of the Products in a way not expressly intended under this Agreement.
9 SkyWater Confidential and Proprietary Rev. 06.2024 9.2 Indemnity by Customer. Customer shall indemnify, defend, and hold harmless SkyWater against and from any third party claim, action, allegation, or proceeding brought against SkyWater and any resulting Loss, against or required to be paid by SkyWater or any Affiliate of SkyWater or any of their Personnel, which results from: (i) Customer’s Intellectual Property constituting an infringement or misappropriation of any Intellectual Property right of a third party; (ii) SkyWater’s compliance with Customer’s instructions, specifications, designs, or requirements in the development, manufacture, sale, use, or shipment of any Products; or (iii) any claims resulting from grossly negligent or intentionally wrongful act or omission of Customer or any Customer Personnel. 9.3 Limitations. The indemnified Party must: (i) promptly notify the indemnifying Party in writing of any such suit or proceeding, (ii) provide the indemnifying Party with sole control over the defense or settlement of such suit or proceeding, and (iii) provide reasonable information and assistance, at the indemnifying Party’s expense, in the defense and/or settlement any such claim or action. The indemnifying Party will not be responsible for any costs, expenses, or compromise incurred or made by the indemnified Party without the indemnifying Party’s prior written consent. 9.4 Disclaimer. THE FOREGOING STATES THE ENTIRE LIABILITY AND OBLIGATION OF THE INDEMNIFYING PARTY AND THE EXCLUSIVE REMEDY OF THE INDEMNIFIED PARTY WITH RESPECT TO ANY ALLEGED OR ACTUAL INFRINGEMENT OF THIRD-PARTY INTELLECTUAL PROPERTY RIGHTS. 10 INSURANCE 10.1 Insurance. Each Party shall procure, and at all times during the term of this Agreement shall maintain, reasonable and customary levels of insurance for its industry with respect to the activities and obligations undertaken by such Party and its Personnel under this Agreement. Each Party shall provide evidence of insurance to the other Party upon reasonable written request by such other Party. 11 REPRESENTATIONS AND WARRANTIES 11.1 SkyWater Warranties. SkyWater represents, warrants, and covenants to Customer that (i) SkyWater has the full right and authority to enter into this Agreement and grant the rights and licenses granted herein; (ii) SkyWater has not previously granted and will not grant any rights that prevent SkyWater from fulfilling its obligations under this Agreement; and (iii) SkyWater will comply with all applicable laws and regulations in connection with its performance under this Agreement. SkyWater further represents and warrants that no SkyWater employee, Affiliate, officer, or director: (i) is listed on the Specially Designated Nationals and Blocked Persons List maintained by United States Office of Foreign Asset Control, (ii) is listed on any published list of terrorists or terrorist organizations maintained by the United States government, or (iii) is otherwise legally prohibited by the United States government from doing business within the United States. 11.2 Customer Warranties. Customer represents, warrants, and covenants to SkyWater that (i) Customer has the full right and authority to enter into this Agreement and grant the rights and licenses granted herein; (ii) Customer has not previously granted and will not grant any rights that prevent Customer from fulfilling its obligations under this Agreement; and (iii) Customer will comply with all applicable laws and regulations in connection with its performance under this Agreement. Customer further represents and warrants that no Customer employee, Affiliate, officer, or director: (i) is listed on the Specially Designated Nationals and Blocked Persons List maintained by United States Office of Foreign Asset Control, (ii) is listed on any published list of terrorists or terrorist organizations maintained by the United States government, or (iii) is otherwise legally prohibited by the United States government from doing business within the United States. 11.3 Disclaimer of Warranties. EXCEPT AS EXPRESSLY PROVIDED ELSEWHERE IN THIS AGREEMENT, SKYWATER AND CUSTOMER EXPRESSLY DISCLAIM ANY WARRANTIES, WHETHER EXPRESS, IMPLIED, STATUTORY, OR OTHERWISE, WITH RESPECT TO PERFORMANCE
10 SkyWater Confidential and Proprietary Rev. 06.2024 HEREUNDER, INCLUDING, WITHOUT LIMITATION, ANY WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. 12 LIMITATION ON LIABILITY 12.1 NEITHER PARTY WILL BE LIABLE WITH RESPECT TO ANY SUBJECT MATTER OF THIS AGREEMENT UNDER ANY CONTRACT, NEGLIGENCE, STRICT LIABILITY, OR OTHER LEGAL OR EQUITABLE THEORY FOR ANY SPECIAL, INCIDENTAL, PUNITIVE, OR CONSEQUENTIAL DAMAGES. EXCEPT FOR LIABILITY ARISING FROM A PARTY'S (A) BREACH OF ITS CONFIDENTIALITY OBLIGATIONS HEREUNDER, (B) INTELLECTUAL PROPERTY INDEMNIFICATION OBLIGATIONS UNDER THIS AGREEMENTRELATING TO INTELLECTUAL PROPERTY INFRINGEMENT OR MISAPPROPRIATION, (C) FRAUD, GROSS NEGLIGENCE, OR WILFUL MISCONDUCT, OR (D) CUSTOMER’S OBLIGATIONS TO PAY FEES AND EXPENSES OWED OR OWING UNDER THE AGREEMENT, IN NO EVENT WILL EITHER PARTY OR THEIR AFFILIATES’ AGGREGATE LIABILITY ARISING FROM THIS AGREEMENT EXCEED THE AMOUNT EQUAL TO THE TOTAL PAYMENTS MADE BY CUSTOMER TO SKYWATER UNDER THIS AGREMEENT DURING THE 12 MONTHS IMMEDIATELY PRECEDING THE EVENT GIVING RISE TO THE LIABILITY. 13 CONFIDENTIALITY 13.1 Confidential Information. Confidential Information includes information disclosed in written, oral, visual or other form that is marked or otherwise identified as confidential, or that, given its nature or the circumstances of disclosure, should reasonably be understood to be confidential. Except as expressly provided herein, the Parties agree that, for the Agreement Term and seven (7) years thereafter, the receiving Party shall keep in confidence and not publish or otherwise disclose, and shall not use for any purpose (except for the purpose of performing its obligations or exercising its rights under this Agreement), any Confidential Information furnished to it, or to which it is otherwise provided access, by the disclosing Party or its Representatives pursuant to this Agreement or prior thereto, whether directly or indirectly, and whether in writing, orally, or by the inspection of tangible objects or data. Notwithstanding the foregoing, with respect to trade secrets disclosed to or accessed by receiving Party, the confidentiality and non-use restrictions of this Agreement shall apply for as long as such information is considered a trade secret under applicable law, Confidential Information shall not include information that, in each case as demonstrated by written documentation: 13.1.1 was already rightfully known to the receiving Party, other than under an obligation of confidentiality, at the time of disclosure by the disclosing Party; 13.1.2 was generally available to the public or otherwise part of the public domain at the time of its disclosure to the receiving Party; 13.1.3 became generally available to the public or otherwise part of the public domain after its disclosure and other than through any act or omission of the receiving Party in breach of this Agreement; 13.1.4 was subsequently lawfully disclosed to the receiving Party without restriction by a third party, other than a Party, who had the right to disclose it, or developed by Personnel of the receiving Party who did not have access to nor use any Confidential Information disclosed by the disclosing Party; or 13.1.5 was independently developed by the receiving Party without the use of or reference to the disclosing Party's Confidential Information. 13.2 Confidentiality and Use Restrictions. Subject to the terms and conditions of this Agreement, each Party agrees that it shall and shall direct its Representatives to use the Confidential Information solely for the purpose for which it was disclosed and as otherwise expressly permitted under the Agreement, that the Confidential Information will be kept confidential, and that the receiving Party will direct its Representatives not to disclose any of the Confidential Information of the disclosing Party; provided,
11 SkyWater Confidential and Proprietary Rev. 06.2024 however, that such information may be disclosed to such Representatives of the Receiving Party who need to know such information in connection with this Agreement. Each Party is responsible for any breach of confidentiality, non-use, and non-disclosure provisions of this Agreement by any of its Representatives. 13.3 Required Disclosures. If a receiving Party is required by law, regulation, or judicial process to disclose any Confidential Information of the disclosing Party, then the receiving Party shall, to the extent legally permissible, give the disclosing Party prompt notice of any such disclosure requirement and the proposed information to be disclosed pursuant to it and reasonably co-operate with the disclosing Party’s efforts to obtain a protective order, at disclosing Party’s sole expense. Notwithstanding anything to the contrary in this Agreement, the receiving Party may disclose any Confidential Information of the disclosing Party as requested by any regulator in the course of any routine, non-targeted inquiry or proceeding without complying with the foregoing notice and cooperation requirements. Receiving Party may disclose the Confidential Information only to the most limited degree permitted by such law, regulation, judicial process, inquiry or proceeding. 13.4 Independent Development. The disclosing Party acknowledges that the receiving Party may currently or in the future develop information internally, or receive information from other parties, that is similar to the Confidential Information. Nothing in this Agreement will prohibit the receiving Party from developing or having developed for it products, or working with others in developing, concepts, systems, or techniques that are similar to or compete with the products, concepts, systems or techniques contemplated by or embodied in the Confidential Information provided that, in doing so, the receiving Party does not use or disclose the other Party’s Confidential Information. This Section 13.4 shall not be construed as permitting any action or inaction that would otherwise violate the Agreement. 13.5 Change of Control; Information Firewall. Following a Change of Control of SkyWater (including the Change of Control that occurred in connection with the acquisition of SkyWater by IonQ, Inc. (“IonQ”) on July 31, 2026) involving a third party that is materially engaged in the design, development, manufacture, supply or commercialization of superconducting or quantum computing technologies (a “Transaction”), SkyWater shall promptly notify Customer in writing and ensure that any such third party does not receive access to Customer’s Confidential Information without Customer’s prior written consent, provided that SkyWater may disclose, without Customer’s prior written consent, to IonQ , only (a) Customer’s financial information to the extent reasonably necessary for the financial or accounting management of SkyWater; and (b) information regarding the existing contractual relationship between Customer and SkyWater, including this Agreement and the applicable Exhibits, to the extent reasonably necessary for legal, compliance, regulatory purposes, or the financial or accounting management of SkyWater. Except to the extent strictly necessary for a specific legal, compliance, or regulatory matter directly relating to SkyWater or its obligations under this Agreement, and only to those personnel with a need-to-know for such purpose, in no event shall SkyWater disclose or provide access to Customer’s Intellectual Property (as specified in Section 8) or any Customer Confidential Information relating to or containing Customer’s product, services or technology roadmaps, development plans, research and development activities, future products, services or technologies, strategic or forward-looking business or technical plans or information, or non-public information concerning Customer’s customers, suppliers, partners or business relationships. Any disclosure of Customer’s Confidential Information other than as expressly permitted in this Section shall require Customer’s prior written consent in each instance. SkyWater shall implement and maintain appropriate technical and organizational measures and safeguards, including information barriers and access restrictions, to prevent any unauthorized access to or disclosure of Customer’s Confidential Information in connection with any Transaction. SkyWater shall remain responsible for any unauthorized disclosure, access or use of Customer’s Confidential Information by any such third party in connection with a Transaction. 13.6 Return or Destruction. Following the termination of this Agreement, upon disclosing Party’s written request, the receiving Party will promptly deliver to disclosing Party or destroy (at the disclosing Party’s option) all the Confidential Information of the disclosing Party, and will direct its Representatives to do the same. Notwithstanding anything in this Agreement to the contrary, nothing contained herein requires the receiving Party or its Representatives to erase any Confidential Information that is in an
12 SkyWater Confidential and Proprietary Rev. 06.2024 archived computer backup system in accordance with its or their respective security and/or disaster recovery procedures, and the receiving Party and its Representatives may each retain copies of the Confidential Information to the extent required to comply with legal, regulatory, or internal documentation retention requirements. All Confidential Information of the disclosing Party retained by receiving Party or its Representatives remains subject to the non-disclosure and non-use obligations under this Agreement. 13.7 Terms of Agreement; Publicity. Except as expressly permitted under this Agreement and except when a disclosure is required by applicable laws including the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder, each Party agrees not to disclose to any third party the financial terms of this Agreement without the prior written consent of the other Party. Any press release relating to this Agreement which is issued by one Party and which mentions the other Party shall be jointly released by the Parties or, if released by one Party, approved by the other Party. SkyWater may disclose that Customer is a customer of SkyWater but may not represent Customer’s process as its own. Customer may disclose that SkyWater is a fabrication contractor for Customer, but Customer may not represent the services or facilities that SkyWater provides to Customer as Customer’s own services or facilities. 13.8 A material breach of a Party’s obligations under this Section 13 constitutes a material breach of this Agreement. 14 TERM AND TERMINATION 14.1 Initial Term and Renewal Term. This Agreement begins on the Effective Date and continues for a period of five (5) years (“Initial Term”). At the end of the Initial Term, the Agreement renews automatically for successive one (1) year periods (each a “Renewal Term”), unless either Party provides the other Party notice of its intention not to renew the Agreement delivered at least six (6) months prior to the end of the Initial Term or then-current Renewal Term (together, the Initial Term and any Renewal Term(s) are the “Agreement Term”). In the event there has been no active Exhibit between the Parties for a period of twelve (12) months, either Party has the right to terminate this Agreement effective immediately upon the provision of written notice to the other Party evidencing its intent to terminate the Agreement. 14.2 Exhibit Term. This Agreement and its Exhibits have separate and independent periods of effectiveness. Unless an Exhibit is also terminated pursuant to its own terms, termination of this Agreement does not also operate to terminate the active Exhibit. In the event this Agreement terminates or expires while any Exhibit remains effective, the terms and conditions of this Agreement survive to the extent necessary to govern that Exhibit. 14.3 Termination for Breach. Either Party to this Agreement may terminate this Agreement or an Exhibit in the event the other Party has materially breached or defaulted in the performance of any of its material obligations under the Agreement or Exhibit (as applicable), and such default has continued for at least thirty (30) days after written notice of the breach was provided to the breaching Party by the non- breaching Party. Failure to make a timely payment required under this Agreement or any Exhibit is a material breach or default hereunder. Any termination under this Section becomes effective at the end of such thirty (30) day cure period unless the breaching Party (or any other party on its behalf) has cured such breach or default prior to the expiration of the thirty (30) day cure period. 14.4 Customer Personnel. No later than the date of termination of this Agreement or an applicable Exhibit, Customer shall use reasonable efforts to cause all Customer Personnel to remove all Customer Personnel personal property from SkyWater premises. SkyWater shall provide reasonable access to the Premises for Customer Personnel solely as needed for the purpose of Customer’s compliance with the preceding sentence, provided Customer Personnel shall comply with SkyWater’s security requirements. After that period, no such persons shall have any right to access SkyWater premises, except such reasonable access as SkyWater and Customer shall agree in advance in writing. SkyWater shall not dispose of or otherwise interfere with any Customer Personnel personal property without providing Customer at least ten (10) business days prior written notice.
13 SkyWater Confidential and Proprietary Rev. 06.2024 14.5 Survival. Notwithstanding any termination or expiration of this Agreement or any Exhibit, any obligation or right of either Party which by its terms or nature necessitates application after termination or expiration of the Agreement or Exhibit, survive such termination or expiration. Sections 5, 7, 8, 9, 11, 12, 13, and 14 survive the expiration or termination of this Agreement for any reason. 15 MISCELLANEOUS 15.1 Governing Law. This Agreement and any dispute arising from the performance or breach hereof are governed by and construed and enforced in accordance with the laws of the State of New York, without reference to conflicts of laws. 15.2 Jurisdiction; Venue. The Parties submit to the exclusive jurisdiction and venue of the state and federal courts located in New York City, New York. The Parties consent to the personal and exclusive jurisdiction of these courts and specifically choose to have any dispute heard and resolved by a judge and waive any right to a trial by jury. Notwithstanding the foregoing, either Party may apply to any court or administrative body of competent jurisdiction to enforce its intellectual property or proprietary rights or to obtain a temporary restraining order, preliminary injunction, permanent injunction, or other injunctive relief to protect its interests, without breach of this Section 15.2, and without any abridgment of the powers of the courts set forth above. The prevailing Party in any action or proceeding arising out of this Agreement is entitled to an award of its reasonable costs and attorneys' fees. 15.3 Assignment. Without the prior written consent of the other Party, which consent shall not be unreasonably withheld or delayed, neither Party, either voluntarily or by operation of law, shall assign, transfer or otherwise dispose of (collectively “Transfer”) this Agreement in whole or in part provided, however, that either Party may Transfer this Agreement without the prior written consent of the other Party to (a) an Affiliate, or (b) a successor in connection with a Change of Control, provided that with respect to (b) such Transfer shall not be permitted where the assignee, transferee or successor is an entity that is engaged in the design, development, manufacture, supply or commercialization of superconducting or quantum computing technologies, unless the non-assigning Party has provided its prior written consent. For the avoidance of doubt, any Transfer of this Agreement to IonQ following the Change of Control of SkyWater resulting from the acquisition of SkyWater by IonQ on July 31, 2026, shall be subject to the restriction in (b) above. All rights and obligations of the assigning or transferring Party are assigned, transferred, or otherwise remain with the respective successor, assignee, or transferee party. Any attempted or purported Transfer of this Agreement which does not comply with this Section 15.3 is null and void, have no force or effect, and confer no rights upon any third parties. Subject to compliance with the provisions of this Section 15.3, the provisions of this Agreement are binding upon and inure to the benefit of the Parties and their respective successors, assigns and transferees. 15.4 Force Majeure. Nonperformance of any Party (other than with respect to payment obligations) is excused to the extent that performance is prevented or delayed by labor dispute or strike, fire, earthquake, flood, power failure, hurricane, tornado, cyclone, typhoon, blizzard, tidal wave, tsunami or other unusually severe weather, acts of foreign or domestic governmental bodies or agencies, terrorism, sabotage, epidemic, civil unrest, travel restriction, quarantine restriction, or any other reason where a failure to perform is beyond the reasonable control of the non-performing Party. 15.5 No Implied Waivers; Rights Cumulative. No failure on the part of either Party to exercise, and no delay in exercising any right under this Agreement, or as provided by statute or at law or in equity or otherwise, impairs, prejudices or constitutes a waiver of any such right, nor does any partial exercise of any such right preclude any other or further exercise thereof or the exercise of any other right. 15.6 Independent Contractors. The Parties are independent contractors. Nothing contained in this Agreement is intended implicitly, or is to be construed, to constitute SkyWater or Customer as partners, joint venturers, or agents in the legal sense. No Party shall have any express or implied right or authority to assume or create any obligations on behalf of or in the name of any other Party or to bind any other Party to any contract, agreement or undertaking with any third party.
14 SkyWater Confidential and Proprietary Rev. 06.2024 15.7 Notices. All notices, requests and other communications hereunder shall be in writing and shall be (1) personally delivered, or (2) sent by national courier service, registered, or certified mail, return receipt requested, postage prepaid, in each case to the respective address specified on the signature page of this Agreement, or such other address as may be specified in writing by one Party to the other Party. 15.8 Modification. Except as expressly permitted under this Agreement, no amendment or modification of any provision of this Agreement is effective unless in writing signed by both Parties. No provision of this Agreement is varied, contradicted, or explained by any oral agreement, course of dealing or performance, or any other matter not set forth in an agreement in writing and signed by both Parties. 15.9 Severability. If any provision hereof should be held invalid, illegal, or unenforceable in any jurisdiction, this Agreement will be deemed amended by the insertion of a valid, legal, and enforceable substitute provision that most nearly reflects the original intent of the Parties, and all other provisions hereof will remain in full force and effect in such jurisdiction, and be liberally construed in order to carry out the intentions of the Parties as nearly as may be possible. Such invalidity, illegality, or unenforceability does not affect the validity, legality, or enforceability of such provision in any other jurisdiction. 15.10 Counterparts. This Agreement may be executed in one or more counterparts, each of which is deemed an original, and all of which together, constitute one and the same instrument. 15.11 Headings. Headings used herein are for convenience only and do not in any way affect the construction of or be taken into consideration in interpreting this Agreement. 15.12 Entire Agreement. This Agreement constitutes the entire agreement, both written or oral, with respect to the subject matter hereof, and supersedes all prior or contemporaneous understandings or agreements, whether written or oral, between the Parties with respect to such subject matter. 15.13 Interpretation. Whenever the context may require, any pronoun used in this Agreement includes the corresponding masculine, feminine, or neuter forms, and the singular form of nouns, pronouns, and verbs include the plural and vice versa. Any references in this Agreement to “including” mean “including without limitation”. 15.14 Non-Exclusive. This Agreement: (a) is non-exclusive; (b) does not restrict either Party from independently (directly or indirectly) acquiring, licensing, developing, making, or distributing technologies, products, or services performing the same or similar functions as any of the other Party’s technologies, products, or services; and (c) does not limit or preclude any Party from entering into similar agreements with third parties. The immediately prior sentence may not, however, be construed as permitting any action that would otherwise violate the Agreement, a right or license by implication to any Party’s intellectual property or other proprietary rights which are provided subject to express limitations and solely for the limited purposes specified in this Agreement. 15.15 Import and Export Compliance. In connection with this Agreement, each Party agrees to comply with all import and export control laws and regulations applicable to its respective performance under the Agreement. Neither Party may export any technical information or technology acquired under this Agreement to any country to which the United States government forbids export, or at the time of export, requires an export license or approval, without first obtaining the required license or approval. [Intentionally Blank; Signature Page Follows.]
15 SkyWater Confidential and Proprietary Rev. 06.2024 IN WITNESS WHEREOF, the Parties have executed this Agreement as of the Effective Date. SKYWATER CUSTOMER /s/ Mihir Bhaskar /s/ Trevor Lanting Signature Signature Mihir Bhaskar Trevor Lanting Name (Print) Name (Print) SVP & GM, Quantum Technologies Chief Development Officer Title Title October 11, 2026 October 11, 2026 Date Date NOTICE ADDRESSES: To SkyWater: SkyWater Technology Foundry Attn: Chief Legal Officer 2401 East 86th Street Bloomington, MN 55425 To Customer: D-Wave Systems Inc. Attn: Chief Legal Officer & General Counsel 3033 Beta Avenue Burnaby, BC V5G 4M9 Canada With a copy to: With a copy to: SkyWater Technology Foundry Attn: Chief Financial Officer 2401 East 86th Street Bloomington, MN 55425 D-Wave Legal Department legal@dwavesys.com [Signature Page of the Agreement]
16 SkyWater Confidential and Proprietary Rev. 06.2024 SCHEDULE A [*****]
Exhibit 31.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002
I, Alan Baratz, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of D-Wave Quantum Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Dated: November 16, 2026 | By: | /s/ Alan Baratz | ||||||
| Alan Baratz | ||||||||
| President and Chief Executive Officer | ||||||||
| (Principal Executive Officer) | ||||||||
Exhibit 31.2
CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002
I, Gregory Golkov, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of D-Wave Quantum Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Dated: November 16, 2026 | By: | /s/ Gregory Golkov | ||||||
| Gregory Golkov | ||||||||
| Acting Chief Financial Officer and Senior Vice President, Finance | ||||||||
| (Principal Financial and Accounting Officer) | ||||||||
Exhibit 32.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of D-Wave Quantum Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2026 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Alan Baratz, President & Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: November 16, 2026 | By: | /s/ Alan Baratz | ||||||
| President and Chief Executive Officer | ||||||||
| (Principal Executive Officer) | ||||||||
Exhibit 32.2
CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of D-Wave Quantum Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2026 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Gregory Golkov, Acting Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: November 16, 2026 | By: | /s/ Gregory Golkov | ||||||
| Acting Chief Financial Officer and Senior Vice President, Finance | ||||||||
| (Principal Financial and Accounting Officer) | ||||||||